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Porcine circovirus is the primary causative agent responsible for inducing a group
of associated diseases known as porcine circovirus associated diseases (PCVAD), which
can have detrimental effects on production efficiency as well as lead to mortality. The
variation in host genetics plays a role in the ability to initiate an effective immune
response. The objective of this research was to identify major genetic variants and genes
that influence immune response and PCVAD susceptibility. Commercial crossbred pigs
(n=974) were experimentally infected with a PCV2b strain to analyze genetic sources of
variation in PCVAD susceptibility. The strain used for experimental infection was
recovered from a pig that displayed characteristic signs of post-weaning multisystemic
wasting syndrome (PMWS). To evaluate the variation in response, blood and weights
were collected from all pigs at days 0, 7, 14, 21, and 28 post infection. Blood samples
were used to analyze PCV2 specific antibody (IgM and IgG) PCV2b viremia. Pair-wise
correlations between phenotypic and genomic prediction values were estimated to
evaluate common sources of variation. In addition, a genome-wide association study
(GWAS) including 56,433 SNPs was performed to analyze the genomic regions

responsible for the variation in host susceptibility to PCV2. The GWAS identified two
important SNPs responsible for explaining approximately 11.5% (ALGA0110477; SSC
12) and 2.8% (ALGA0039710; SSC 7) of the genetic variation observed for viral load.
Negative correlations between average daily gain (ADG) and viral load during the
experimental challenge (r= -0.36, P<0.0001). Pigs exhibiting the CC genotype for the
ALGA0110477 SNP demonstrated lower viral load (P< 0.0001) and higher overall ADG
(P< 0.05) compared to the CT and TT genotypes. These genetic variants influence the
host’s ability to stimulate immune response, and can therefore be utilized for selection to
reduce PCV2b susceptibility. Selection based on these DNA markers can improve
general animal health and welfare, provide an alternative to vaccinations, and decrease
production costs.
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1
INTRODUCTION

The first discovery of porcine circoviruses (PCV) occurred in 1974, when Tischer
and others discovered a contaminant of porcine kidney cell lines PK-15 (ATCC-CCL31)
(Tischer et al., 1974); however, it wasn’t until 1982 when the first true description of the
agent was given (Tischer et al., 1982).
Porcine circoviruses (PCV) are small, non-enveloped, icosahedrical, DNA viruses
(Lukert et al., 1995) that are classified within the Circoviridae family and Circovirus
genus (Meng X. J., 2013a). PCV are one of the smallest classifications of DNA viruses
capable of infecting and replicating in mammalian cells (Kim et al., 2004b). The most
notable PCV is porcine circovirus type 2 (PCV2), which is an economically important
pathogen because it has the capability to infect large populations due to its infectious
proficiency. PCV2 is the etiological agent responsible for inducing the development of
porcine circovirus associated diseases (PCVAD), which is a multifactorial disease that
impacts production efficiency and increases mortality rates (Opriessnig et al., 2006a).
PCV2 contains a circular, single-stranded DNA genome that consists of 1768 nucleotides
(Gillespie et al., 2009), and PCV2 uses three open reading frames (ORF) for replication
(Meng, 2013a). ORF1 encodes for non-structural, replicase proteins that facilitates viral
replication. ORF2 encodes for capsid proteins (Cap) to protect the viral DNA (Hamel et
al., 1998; Mankertz et al., 1998; Nawagitgul et al., 2000; Carman et al., 2008). The
function of ORF3 is not entirely understood, but it has been suggested that it encodes a
non-structural protein involved with apoptosis in vitro and viral pathogenesis in vivo (Liu

2
et al., 2006) and that it plays a role in the systemic spread of infection by recruiting
macrophages (Karuppannan et al., 2011).
PCV2 is divided into two sub-categories consisting of PCV2a and PCV2b. PCV2a
was first identified in North America and PCV2b was first identified in Europe (Takahagi
et al., 2009). Previous research has established that PCV2b is more virulent than PCV2a,
and is the major causative agent of PCVAD.
The major signs characterized by PCV2 infections include weight loss, skin
discoloration, respiratory signs, diarrhea, interstitial pneumonia, nephritis, reproductive,
dermatitis as well as lymphoid depletion (Harding and Clark, 1997; Krakowa et al.,
2002). Although the pathogenesis of the virus is not fully understood, it has been
suggested that the virus invades macrophages and dendritic cells, which causes
immunosuppression (Opriessnig et al., 2007). PCV2 is the contributing factor in PCVAD
development, which includes several diseases such as post-weaning multisystemic
wasting syndrome (PMWS), porcine reproductive failure, porcine respiratory disease
complex (PRDC), and porcine dermatitis and nephropathy (PDNS). PCVAD progression
is dependent on several factors including PCV2 isolate, presence of co-infections, and
age at infection.
Previous research has indicated host factors such as level of maternal antibodies
and host genetics play a role in the variation in PCVAD response in several breeds of
pigs such as Landrace, Large White, Duroc, and Pietrain (Zhou et al., 2006; Opriessnig et
al., 2006a; Opriessnig et al., 2009b; Bates et al., 2009). For instance, numerous reports
have indicated that Landrace pigs have increased vulnerability to PCV2 infections
compared to Large White, Yorkshire, Duroc and Pietrain pigs (Zhou et al., 2006;
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Opriessnig et al., 2006a). Although research has demonstrated that PCV2 vaccinations
have an effect on ADG, mortality rates, viremia, shedding and the overall occurrences of
PCVAD, they increase production costs. In order to prevent outbreaks, every pig in the
operation has to be vaccinated, which also increases labor and stress to the animals.
Selection for less susceptible animals could be an alternative to vaccinations as well as
complementary tool for extra protection in swine operations that experience high
pathogen exposure. Eventually the use of selection could be implemented into common
swine management practices to increase pathogen prevention and control.
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CHAPTER 1
LITERATURE REVIEW

PCV2 History and Origin
Although porcine circovirus type 2 (PCV2) has become a prevailing pathogen in
the global swine industry, the history and origin of the virus is fairly recent. The earliest
documented evidence of PCV2 infection in pigs was detected using in situ hybridization
and polymerase chain reaction in tissue samples from 1962 in pigs that originated from
Northern Germany (Jacobsen et al., 2009). In 1974, Tischer initially discovered a
contaminant of the porcine kidney cell lines PK-15 (ATCC-CCL31), which was
described as a picornavirus-like virus (Tischer et al., 1974). It wasn’t until 1982, when
Tischer gave the first true description of the contaminant agent as a circular single
stranded DNA virus, which was eventually named Porcine Circovirus (PCV), and today
is known as PCV type 1 (Tischer et al., 1982).
In a study involving an experimental infection of PCV, Tischer et al. (1986)
demonstrated that the virus did not elicit clinical disease, nor where there detectable sites
of viral replication. Serological examinations performed on blood samples collected in
the experimental population did reveal the presence of PCV antibodies; however, no
clinical disease could be attributed to the PK-15 (ATCC-CCL31) isolate and was
therefore considered to be non-pathogenic (Allan et al., 1994; Dulac and Afshar 1989;
Tischer et al., 1986).
In 1995, Allan et al., confirmed these results and demonstrated that infecting
Cesarean-delivered and colostrum deprived pigs did not elicit clinical illness, or produce
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lesions; however viral replication was detected (Allan et al. 1995; Tischer et al. 1986).
The PCV isolate was eventually assigned to the Circoviridae family (Lukert et al., 1995).
Until the early 1990s, the common notion was that PCV was considered to be
non-pathogenic; however, in 1991, Canadian swine producers began experiencing a
newly developing disease in high-health herds (Opriessnig et al., 2006a). It was estimated
that only 2.5% of collected tissues profiled from a large set of animals between 1962 and
1984 were infected with PCV2; however, in 1985, the prevalence of PCV2 increased
substantially to over 30% (Trible et al. 2012).
This new disease syndrome was characterized by rapid loss of weight, and
respiratory distress and termed post-weaning multisystemic wasting syndrome (PMWS)
and was officially reported first in western Canada in 1991 (Clark, 1997; Harding, 1997).
PMWS is characterized by a variety of clinical signs including wasting in weaned pigs,
dyspnea, palpable lymphadenopathy, diarrhea, pallor and lymphoid depletion in
lymphoid tissues (Allan et al., 2000a; Opriessnig et al., 2006a).
Later studies revealed an association between PMWS and a new antigenically and
genomically distinct PCV global swine population (Allan and Ellis, 2000). It was
proposed that this new circovirus should be designated as PCV type 2 (PCV2) and the
non-pathogenic contaminant of the porcine kidney cell lines PK-15 should be designated
PCV type 1 (PCV1)(Allan et al., 1998b; Meehan et al., 1998). In 1998, the first PCV2
isolation and characterization of PCV2 isolates occurred as well as the first sequences of
the complete PCV2 genome became available (Allan et al., 1998a; Ellis et al., 1998;
Meehan et al., 1998; and Morozov et al., 1998).
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PCV2 is also associated with numerous other syndromes including porcine
dermatitis and nephropathy syndrome (PDNS)(Rosell et al., 2000), porcine respiratory
disease complex (PRDC), sporadic reproductive failure (West et al., 1999), and porcine
respiratory-disease complex in North America (Harms et al., 2002; Opriessnig et al.,
2004b). In order to group all of the diseases and syndromes associated with PCV2, the
term porcine circovirus associated diseases (PCVAD) was proposed in 2002 by the
American Association of Swine Veterinarians (AASV) to collectively name conditions
triggered by the same pathogen (Allan et al., 2002).

Taxonomy
Both types of the porcine circovirus are classified in the genus Circovirus, which
is within the Circoviridae family (Meng X. J., 2013a) and are known to infect birds and
pigs (Linlin et al., 2010). The genomic organization as well as the replication approach of
circoviruses is analogous with members of plant geminiviruses and nanoviruses (Meng
X. J., 2013a). Currently there are at least 11 species of circoviruses including PCV1 and
PCV2 and numerous avian circoviruses (Meng X. J. 2013b) including beak and feather
disease virus (Ritchie et al., 1989), pigeon circovirus (Woods et al., 1993), canary
circovirus (Phenix et al., 2001), goose circovirus (Todd et al., 2001), duck circovirus
(Hatterman et al., 2003, finch circovirus (Shivaprasad et al., 2004) and gull circovirus
(Smyth et al, 2006).
Members of the Circoviridae family consist of small, icosahedrical, singlestranded DNA (ssDNA) viruses that infect vertebrates (Lukert et al., 1995). Porcine
circoviruses are one of the smallest DNA viruses that are capable of infecting mammals
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and replicating independently in mammalian cells (Kim et al., 2004b). Circoviruses have
circular genomes and range in size from 1.8 to 2.3 kilobases (Opriessnig et al., 2007).
In addition, circoviruses are non-enveloped also known as naked viruses, which
consist of nucleic acid (DNA) and a protein capsid to protect the viral genome. The
nucleocapsids of naked viruses attach themselves to the target cells of the host; where as
enveloped viruses fuse their envelope with host membranes. Using disinfectants to
eliminate circoviruses is difficult because circoviruses are non-enveloped viruses, which
makes them resistant to various sterilizers such as those with alcohol, chlorhexidine,
iodine, and phenol bases (Grau-Roma et al., 2011).

Porcine Circovirus Characteristics
Porcine circoviruses are among the smallest animal viruses with a virion particle
diameter of 17±1.3 nm (Tischer et al., 1982) consisting of a circular, negative sense,
single stranded genome approximately 1.7kb (Chae, 2005; Meng, 2013b). The
icosahedral virion contains 60 capsid protein subunits, which are arranged in 12 flat
pentamer clustered units (Crowther et al., 2003; Khayat et al., 2001).
Porcine Circoviruses are broken up into type 1, which is considered to be nonpathogenic and type 2, which is pathogenic. Currently research involving porcine
circoviruses is primarily focused on type 2 because it has been shown to produce clinical
illness and contributes to several diseases (Finsterbusch and Mankertz, 2009). Although
they differ in virulence, porcine circovirus type 1 and type 2 share about 75% nucleotide
sequence identity (Opriessnig et al., 2006b).
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Porcine circovirus genomes have slightly varying genomes. For instance PCV1
isolates range from 1,758 to 1,760 base pairs, while PCV2 isolates range from 1,767 to
1,768 base pairs (Allan et al., 1998b; Hamel et al., 1998; Meehan et al., 1998; Morozov et
al., 1998; Fenaux et al., 2000; Opreissnig et al., 2006b; Huang et al., 2011). Nucleotide
sequence identity between the PCV1 isolates as well as between the PCV2 isolates is
greater than 90% (Hamel et al., 1998; Meehan et al., 1998; Morozov et al., 1998; Cheung
and Bolin, 2002).

Porcine Circovirus Genomic Organization
PCV1 and PCV2 have similar genomic organization, consisting of 11 potential
ORFs (Hamel et al., 1998). To enhance efficiency, the genomic organization of PCVs is
reduced to absolute necessities to achieve the two basic functions of a virus, which is to
copy and package the viral genome (Meng, 2013a). Therefore, porcine circoviruses rely
on three major open reading frames (ORFs) to replicate.
For instance, ORF1, which is located on the positive strand of the genome and is
positioned in the clockwise direction, facilitates viral replication. ORF1 encodes for nonstructural, viral replicase proteins Rep (35.7 kDa) and a frame-shifted variant Rep’ (20
kDa), which has been alternatively spliced (Mankertz et al., 1998; Mankertz and
Hillenbrand, 2001;Mankertz et al., 2003). Both of these proteins are involved in viral
replication; however, sequence size varies slightly between PCV1 and PCV2. For
example, PCV1 Rep and Rep’ contain 312 and 168 amino acids, while PCV2 Rep and
Rep’ contain 314 and 178 amino acids (Hamel et al., 1998). ORF1 is the most conserved
reading frame between PCV1 and PCV2 having 83% nucleotide identity and 86% amino
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acid identity (Meehan et al., 1998; Morozov et al., 1998). Mutations in either the Rep or
Rep’ replicase proteins can cause a 99% decrease in viral protein synthesis, which
terminates viral DNA replication (Cheung et al., 2003).
In addition, ORF2, which is located on the negative strand of the genome and is
positioned in the counter-clockwise direction encodes for viral capsid proteins (Cap) to
protect the viral DNA (Hamel et al., 1998; Meehan et al., 1998; Morozov et al., 1998;
Mankertz et al., 1998; Nawagitgul et al., 2000; Carman et al., 2008). PCV1 Cap protein
contains 230-233 amino acids, while PCV2 Cap protein contains 233-236 amino acids
(Hamel et al., 1998; Nawagitgul et al., 2000; Lefebvre et al., 2008; Lefebvre et al., 2009;
Huang et al., 2011). ORF2 is less conserved between PCV1 and PCV2 compared to
ORF1. For instance, PCV1 and PCV2 share 67% nucleotide identity and 65% amino acid
sequence identity (Hamel et al., 1998; Meehan et al., 1998; Morozov et al., 1998; Fenaux
et al., 2000). Because Cap is the most variable protein in the PCV genome, it has been
proposed that there might be an association between the varying Cap proteins and the
level of pathogenicity of PCV2 (Larochelle et al., 2002).
ORF3 is located on the complementary strand in a counter-clockwise position.
The entire reading frame of ORF3 overlaps ORF1 (Hamel et al., 1998; Meehan et al.,
1998; Morozov et al., 1998). ORF3 encodes a non-structural protein that in PCV1
contains 206 amino acids (23.2 kDa) and in PCV2 contains 104 amino acids (11.9 kDa).
Between PCV1 and PCV2, ORF3 proteins share 62% identity (Hamel et al., 1998;
Meehan et al., 1998). ORF3 is involved with apoptosis in vitro and viral pathogenesis in
vivo (Liu et al., 2006); however these results have not been replicated as explained in a
review by Juhan et al., 2010. In addition, OFR3 has also suggested participation in the
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systemic spread of the infection by facilitating the recruitment of macrophages for
infection (Karuppannan et al., 2011). Recent research in both mice (Karuppannan et al.,
2009) and pigs (Juhan et al., 2010) has demonstrated that mutations in ORF3 resulted in
decreases in PCV2 viremia; though no differences in gross or microscopic lesions were
detected.

Porcine Circovirus Type 1
Although PCV1 infections occur worldwide, research and information involving
pathogenesis has not been well studied because it is considered to be non-pathogenic
(Allan et al., 1998a; Allan and Ellis, 2000; Fenaux et al., 2000). It is assumed that
transmission of PCV1 transpires through ingestion and/ or inhalation (Tischer et al.,
1986); however, some research has shown that shedding can also occur in the milk of
sows, which transmits to newborn pigs through colostrum (Shibata et al., 2006). There
has been a limited number of experimental PCV1 inoculations performed on 1 day old, 2
days old, 1 month old, and 9 months old pigs to look at the pathogenesis (Tischer et al.,
1986; Allan et al., 1995). Furthermore, these experimental PCV1 inoculations did not
elicit clinical illness. (Allan et al., 1995; Krakowa et al., 2000;).
PCV1 has been isolated from nasal secretions at 3 days post inoculation (dpi) as
well as from fecal samples at 14 dpi; however, the inoculation did not initiate disease, or
any increase in body temperature (Tischer et al., 1986). PCV1 has also been isolated from
serum and plasma, which indicates that PCV1 is distributed throughout the body through
infected monocytes in the bloodstream (Allan et al., 1995). At 3 dpi, PCV1 antigens can
be detected in nasal mucosa and other various tissue types including liver, spleen, lung,
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thymus, and bronchial lymph nodes and also small intestine at 5 dpi (Allan et al., 1995).
The distribution of PCV1 antigens increases significantly at 7 to 9 dpi (Allan et al.,
1995). PCV1-specific neutralizing antibodies begin to appear at 7 dpi, which causes a
decrease in PCV1 antigens. The amount of PCV1-specific antibodies rapidly increases
between 2 to 5 weeks post infection to eliminate the infection. Once the infection is
cleared, the levels of PCV1-specific antibodies begin to decrease; but are still detectable
until 39 to 47 weeks post inoculation (Tischer et al., 1986).
PCV1 antigens can be detected in various tissue types, but are primarily present in
cells of the spleen, thymus and lung (Allan et al., 1995). PCV1 antigens are generally
detected in non-epithelial cell types that are morphological similar to macrophages,
histiocytes, dendritic cells and other antigen presenting cells; however, primary sites of
viral replication are still unknown (Allan et al., 1995).

Porcine Circovirus Type 2
PCV2 can be divided into three sub-categories based on genomic DNA
sequencing including PCV2a, PCV2b, and PCV2c. Of these sub-categories, PCV2a and
PCV2b are the most common and occur worldwide. PCV2a was most commonly
detected in North America, while the PCV2b was identified in Europe (Takahagi et al.,
2009). Initially, PCV2a was the predominate genotype; however, in 2000 PCV2b entered
into North America most likely from Europe and spread across the continent, triggering
high mortality and morbidity. The rapid spread of PCV2b in North America had
devastating effects in major swine production region. Various studies presented in a
review article conducted by Grau-Roma et al. (2011) demonstrate that PCV2b is more
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prevalent in natural infections, which may indicate that PCV2b has a higher virulence and
is more persistent in the environment compared to PCV2a. In a review paper written by
Grau-Roma and others in 2011, several studies confirm that PCV2b is the most common
natural infecting strain. In addition, PCV2b is also considered to be more virulent
compared to PCV2a, which is associated with non-PMWS-affected farms (Carmen et al.,
2008 and Grau-Roma et al., 2008).
Most PCV2 infections predominately occur through the nasal route and are shed
through nasal, ocular, and oral secretions in addition to milk, urine, semen, and feces
(Krakowa et al., 2000; Larochelle et al., 2000; Kim et al., 2001; Segalés et al., 2005).
Furthermore, pigs that are clinically infected will shed PCV2 at a higher rate compared to
sub-clinically infected pigs (Segalés et al., 2005).
One of the most problematic issues involving PCV2 infections is that some pigs
can remain asymptomatic, which can make diagnosis extremely difficult. Highly viremic
pigs may develop any of the diseases associated with PCV2 infections.

Pathogenesis
The events leading to initial stages of PCV2 infection and replication are still
somewhat ambiguous to research scientists; therefore, further research is a necessity to
make conclusive assumptions. PCV2 is capable of infecting dendritic cells (DC) and
modulating their activity; however, they show no evidence of replicating in these cells
(McCullogh et al., 2009). It has been suggested that PCV2 infections seem to cause
lymphoid depletion and a reduction in levels of lymphocytes in peripheral blood, which
can lead to reduced bone marrow production, reduced proliferation in secondary
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lymphoid tissues, and reduced levels of lymphocytes in bone marrow, peripheral blood,
or secondary lymphoid tissues (Opriessnig et al., 2007). PCV2 can be detected as early as
7 dpi; however, viral titres peak between 14 and 21 dpi (Rovira et al., 2002; Resendes et
al., 2004; Opriessnig et al., 2008a). By the second week of infection, PCV2 can be
detected in numerous tissue types and several organs, though lymphoid tissues are
primary sites of infection and typically contain the highest levels of viral load.
Although it has been demonstrated that PCV2 establishes itself in both
macrophages and dendritic cells, previous studies involving in vitro models have
determined that monocytes are not sites of PCV2 replication (Opriessnig et al., 2007).
PCV2 infected pigs have demonstrated that the highest levels of PCV2 virions exist in the
cytoplasm of monocyte/macrophage lineage cells (Rosell et al., 1999; Sanchez et al.,
2004). In addition, in vitro studies have also demonstrated that PCV2 is able to infect
theses cells and persist; however, without replication (Gilpin et al., 2003; Vincent et al.,
2003). A review by Opriessnig et al., 2007 describes the work of Gilpin et al., 2003, and
describes that macrophages and monocytes were tested for PCV2 replication, though
replication was not observed. The PCV2 genome does not code for its own replication
machinery, such as its own DNA polymerases. Instead, the virus relies entirely on host
cells that are in the S-phase to complete its infectious cycle (Tischer et al., 1987).
Because of this, the general assumption is that cells with higher mitotic rates are the most
efficient in facilitating PCV2 replication.
Although monocytes may not be the primary site of PCV2 replication, it has been
proposed that they might be involved in the mechanism responsible for systemic-spread
(Vincent et al., 2003). PCV2 is also able to stimulate deficiency of in vitro cultured
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dendritic cells (DC) (Vincent et al., 2005). Because dendritic cells can initiate an
immune response, control lymphocyte homeostasis, and exist in many locations such as
the skin, mucosal surface, and circulating in blood they are able to respond to viruses
very quickly. Dendritic cells also encapsulate antigens and travel to lymph nodes and
organs to initiate T cell activation to increase immune response (Vincent et al., 2003). A
study conducted in 2003 by Vincent and others, determined that bone marrow derived
and monocyte-derived dendritic cells were affected by PCV2 infections. Additionally, a
review conducted by Opriessnig et al., (2007), further described Vincent’s work and
demonstrated that although PCV2 was able to exist in dendritic cells without initiating
apoptosis, replication did not occur in dendritic cells.
Furthermore, it has been proposed that dendritic cells could be exploited as means
of transportation because of their capability to move throughout the body. Because
dendritic cells play a vital role in mediating innate and virus-specific immune response,
understanding the mechanism of dendritic cell impairment may be critical in clarifying
the immune events during PCV2 infections. In 2002, Fenaux and others performed a
cutting-edge study where an infectious clone of PCV2 was developed to examine its role
in systemic diseases. Specific pathogen-free pigs were injected with the PCV2 clone
directly into the liver and superficial iliac lymph nodes. PCV2 antigen was detected in
various tissue types at 35 dpi and lesions were discovered in the lymph nodes as well as
the lungs. This study is significant in a sense that it proved that transfection could be used
in vivo to study the associations of PCV2 genes to evaluate their functions in viral
replication and pathogenesis.
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After 14 dpi, specific PCV2 immune responses begin to develop (Pogranichnyy et
al., 2000; Resendes et al., 2004a; Meerts et al., 2005). It has been proposed that the
capability to initiate a sufficient adaptive immune response can prevent PCV2
progression towards PMWS. For instance, the induction of PCV2 antibody development
is usually followed by a decline in viral titres, which typically results with viral
dissipation (Resendes et al., 2004a; Meerts et al., 2005; Fort et al., 2007; Opriessnig et
al., 2008b).
Sub-clinically affected pigs that tend to demonstrate lower PCV2 viremia,
typically experience minimal modifications of the immune system allowing the host to
recover from the infection. However, there have been reports of sub-clinically infected
pigs that demonstrate high antibody titres, long-term viremia as well as detection of
PCV2 in various tissues (Allan et al., 1999; Pogranichnyy et al., 2000; Resendes et al.,
2004). In addition, a reduction in humoral responses, such as a decrease in neutralizing
antibodies (NA) (Meerts et al., 2006) is associated with an increase in viral replication.
Of the PCV2 specific antibodies, IgG is predominantly associated with neutralizing
capacity (r= 0.85, P< 0.001) (Fort et al., 2007). This results in severe lymphoid lesions
and major immune system alterations, which could induce an immunosuppressive state,
leading to PMWS.
The cause of why certain pigs develop clinical symptoms, while others do not, is
not clearly understood; however, a review conducted by Opriessnig and others in 2007
described several factors that influence PCV2b progression/reduction, such as virusdependent factors, host dependent factors, effects of co-infections and immune
modulation.
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Virulence
There are numerous factors that influence PCV2 pathogenesis and disease
progression. One of the most important influences is virulence, which varies depending
on the strain. Certain isolates may induce clinical symptoms further driving PCV2
disease progression, while other strains may not show any indications of infection.
A majority of the U.S. swine herds are infected with PCV2 (Allan and Ellis 2000;
Opriessnig et al., 2006a) and most pigs will become exposed to PCV2 at some point
during the growing period (Larochelle et al., 2003; Opriessnig et al., 2006a). Although
several farms have reported high PCV2 prevalence with high mortality, many other herds
do not report any evidence of PCV2 clinical symptoms (Larochelle et al., 2003;
Opriessnig et al., 2006a). Virulence differences in PCV2 isolates could be one potential
assertion to the differences in PCV2 intensity (Opriessnig et al., 2006a).
Opriessnig and others (2006b) carried out a study comparing two different PCV2a
isolates (PCV2-40895 and PCV2-4838) to evaluate virus sequence differences and to
determine the difference in the pathogenicity of the PCV2 isolates. The isolates were
selected based on field cases with and without PCV2-associated lesions (Opriessnig et al.,
2006b). The first strain, PCV2-40895, was isolated from a pig diagnosed with postweaning multisystemic wasting syndrome and exhibited lymphoid depletion, high levels
of PCV2 antigens as well as histiocytic replacement of lymphoid follicles. The second
strain, PCV2-4838, was isolated from a pig from a herd symptomatic of respiratory
disease. In addition, Streptococcus suis, Pasteruella multiocide, and Mycoplasma
hyopneumoniae were also isolated from this pig. Although PCV2 DNA was detected in
this pig, no indications of PCV2-associated lymphoid lesions were present.
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There were observable differences in several parameters between PCV2-40895
and PCV2-4838 such as levels of PCV2 in serum and lymphoid tissues and serum
antibody profiles as well as the severity of PCV2-associated gross and microscopic
lesions were observed (Opriessnig et al., 2006b).
Both PCV2-40895 and PCV2-4838 genomes were sequenced and were each
found to contain 1768 base pairs. Between the isolates, there was an overall 98.9%
nucleotide sequence identity with 20 nucleotide differences. The isolates shared a 99.5%
nucleotide and 99.4% amino acid sequence identity for ORF1 with 5 nucleotide
differences. In addition, the isolates shared a 98.0% nucleotide and 96.1% amino acid
identities with 14 nucleotide differences in the ORF2 capsid gene. In ORF3, the isolates
shared a 99.0% nucleotide and 99.7% amino acid sequence identities, with one nucleotide
difference. Although the two PCV2 isolates were genetically similar having an overall
nucleotide sequence identity of 98.9%, PCV2-4838 was demonstrated to be less virulent
compared to PCV2-40895, suggesting that different isolates can have varying effects.
In another study conducted by Opriessnig and others (2008), 113 pigs were
inoculated with one of four different PCV2 isolates. The isolates used in this study were
PCV2-40895 and PCV2-4838 (now known as ISU-40895 and ISU-4838), NC-16845 and
CAN-17639. The NC-16845 strain was isolated from a pig exhibiting specifically
lymphadenitis and bronchointerstitial pneumonia. The CAN-17639 strain was isolated
from a pig exhibiting wasting, coughing, and bronchointerstitial pneumonia. The strains,
ISU-40895 and ISU-4838 were classified as PCV2a, while NC-16845 and CAN-17639
were classified as PCV2b. Overall, these four sequences shared a 95.7% nucleotide
sequence identity, while the PCV2b isolates shared a 99.9% nucleotide sequence identity.
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Because none of the isolates induced PCV2 clinical symptoms, nor were there any
differences in macroscopic lesions, this study can only be used to analyze PCV2
differences between the isolates, and not the differences in their clinical effects.
In a study conducted by Grierson and others (2004), 10 PCV2 isolates from the
Netherlands were examined. Four strains were taken from farms experiencing clinical
signs of PMWS, and the other six strains were taken from farms with no evidence of
PMWS. The isolates were sequenced and aligned, demonstrating that the ten strains
shared between 95.6% and 100% nucleotide sequence identity with 77 nucleotide
differences. Although the farms presented different levels of clinical symptoms, no
consistent pattern was observed between the PCV2 isolates from affected and control
pigs.
In similar study in 2004, de Boisseson and others examined isolates from 23
swine herds in France. A different strain was isolated from each herd. Ten of the isolates
did exhibit evidence of PMWS and were classified as PMWS negative, while the other 13
did demonstrate PMWS symptoms and were classified as PMWS positive. There was a
much greater range of nucleotide diversity in the PMWS negative isolates, sharing 94.6%
to 99.9% nucleotide sequence identity, compared to the PMWS positive isolates, which
only shared a 99.5% to 99.9% nucleotide sequence identity. In addition, two clusters
were identified. Isolates from France, the United Kingdom, and the Netherlands were
categorized into Cluster I, while isolates from North America, Asia, Germany, and Spain
were categorized as Cluster II. The results from this study reveal that different PCV2
isolates have varying effects on the progression of PMWS, despite the cluster they belong
to. For example, some pigs displayed clinical symptoms, while others did not.
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Because most of the U.S. swine herds are infected with PCV2 and most pigs will
likely be exposed to PCV2, with only few a herds experiencing severe mortality and
morbidity associated with PCV2 infection, it has been suggested that the majority of the
PCV2 isolates are non-virulent or of low virulence. Therefore understanding the
molecular basis of virulence of PCV2-associated diseases may aid in developing effective
vaccines to improve PCV2 diagnosis.

Breed Differences
Another significant influence of PCV2 pathogenesis and disease progression is
host susceptibility. There have been reports on genetic differences in cattle and poultry
that influence susceptibility of populations or breeds to parasites, bacteria, and viruses
(Bumstead et al., 1988; Harmon et al., 1989; Bumstead et al., 1993; and Stear et al.,
1998). In addition, there is evidence for specific breed differences in disease resistance to
various pathogens including pseudorabies virus (Reiner et al., 2002), PRRSV (Halbur et
al., 1998a), Escherichia coli (Duchet-Suchaux et al., 1991; Michaels et al., 1994) and
Sarcocystis miescheriana (Reiner et al., 2002). Although research has demonstrated that
all pig breeds worldwide are capable of contracting a PCV2 infection, the degree of
susceptibility differs across breeds. In addition, veterinarians, producers, and pig genetic
companies have recently shown significant interest in determining if there is a potential
genetic host component that has a role in influencing PCV2 susceptibility, expression of
PCVAD and disease progression. Although successful vaccines have recently become
available (Fachinger et al., 2008; Fort et al., 2008; Opriessnig et al., 2008b), they increase
production costs and are labor-intensive. If identified, a DNA marker could possible
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allow for selective breeding, which might reduce PCVAD occurrence in some swine
herds.
Anecdotal information from veterinarians and producers in the field suggests that
there are genetic differences within the host effecting susceptibility to PCV2-associated
diseases Therefore, several studies have been performed to determine if there are breed
differences in susceptibility to PCV2. For instance, a study conducted by Opriessnig and
others (2006a) evaluated the difference in susceptibility between three breeds of pigs.
Seventy-five colostrum-fed, female purebred pigs raised under identical conditions were
selected from the same farm, which had no evidence of PCV2-associated diseases. The
experimental pigs consisted of Duroc (=26), Landrace (n=25), and Large White (n=24)
were inoculated with a single strain of PCV2 (ISU-40895) intranasally and
intramuscularly at 5 to 7 weeks of age (Opriessnig et al., 2006a). All experimental pigs
were scored for clinical symptoms, tested serologically and underwent histological
examination and immunohistochemical analysis. The results form this study
demonstrated that Landrace pigs had significantly more severe lymphoid depletion in the
lymph node pool and the tonsil region compared to Duroc and Large White pigs. In
addition, microscopic lesions characteristic of PMWS were not developed in Duroc and
Large White pigs, but were identified in 15.8% of Landrace pigs. Although the there was
no significant difference in PCV2 susceptibility as indicated by viremia, genomic DNA
copy counts, and anti-PCV2 antibody levels, there was a difference in the amount of
lesions characteristic of PMWS in Landrace pigs compared to Duroc and Large White
pigs. These results indicate that Duroc and Large White pigs are as susceptible to PCV2
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infections as Landrace pigs; however, Landrace pigs may have a higher vulnerability for
PCVAD compared to Duroc and Large White pigs.
Another study done by Opriessnig and others (2009) was performed to determine
if possible host genetic differences exist between Landrace and Pietrain breeds under
experimental conditions. In this study, 78 pigs including 39 Landrace and 39 Pietrain pigs
were used to evaluate breed susceptibility. The experimental animals were broken up into
four treatments: Landrace negative control noninoculated (n=13), Landrace PCV2infected (n=26), Pietrain negative control noninoculated (n=13), and Pietrain PCV2infected (n=26). After passively acquired anti-PCV2 antibodies had declined within the
selected pigs, the experimental pigs were inoculated with a PCV2 isolate (ISU-40895). At
21 days post infection (dpi), all of the pigs were necropsied. The results from this study
suggest that there are some differences between Landrace and Pietrain pigs, which
contributes to susceptibility to PCV2-associated lesions. From the sampled pigs, the
Landrace pigs were more susceptible to PCV2-associated lesion and the Pietrain pigs
were less susceptible to PCV2-associated lesions. The results from this study support
anecdotal reports from the field.
A study conducted by Rose and others in 2005 was done to evaluate an assumed
Pietrain resistance. This study involved 540 pigs born from three groups of boars:
Pietrain, and two groups of random boars (Rose et al., 2005). All of the pigs were
evaluated based on clinical symptoms, and were tested serologically. The overall average
rate of PMWS manifestation was 18%, and the morbidity rate of random-sired pigs was
17.3%, while the morbidity rate in Pietrain-sired pigs was 16.3%(Rose et al., 2005). The
results from this study indicate that Pietrain pigs may possess a genetic component
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capable of reducing the development of PCVAD. Although these results may suggest
Pietrain resistance, further research is needed to confirm the assumption of Pietrain
resistance.

Maternal Antibodies
Because piglets are born with low body energy reserves, lack effective immune
protection, and are exposed to a cold environment and pathogens, they are at risk for
disease contraction. Therefore, newborn pigs must obtain immune protection as well as
activate mechanisms responsible for heat production to supply energy to its heat
producing tissue (Le Dividich et al., 2005). In order to acquire immune protection and
energy, newborn piglets feed off of the sow first with colostrum and then with milk.
Through colostrum the sow provides immunity to the offspring, by delivering the
necessary immunoglobulins to jump-start the pig’s immune system. The antibody
composition of effective colostrum should contain about 30% IgA, 10% IgM, and 60%
IgG. These passively acquired antibodies protect against most viral infections to newborn
piglets (McKeown et al., 2005).
A study conducted by McKeown and others (2005) evaluated the role of
maternally derived antibodies and their effect on reducing the occurrences of PCV2
infection. In this study, 106 specific-pathogen free piglets free of M. hyopneumoniae and
porcine reproductive and respiratory syndrome virus (PRRSV) were selected from a
commercial source. The piglets were selected at 12 days of age and were tested for the
presence of maternal antibodies by a PCV2-specific enzyme-linked immunosorbent assay
(ELISA) (Nawagitgul et al., 2002). From the group of 106 piglets, 24 were selected for
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the experimental infection based on titres of PCV2 maternal antibodies. The 24 selected
piglets were categorized based on antibody titres. Group A, consisted of 6 pigs that were
considered negative for PCV2 maternal antibodies, group B consisted of 5 pigs with low
PCV2 maternal antibody levels, and both groups C containing 8 piglets, and group D
containing 5 piglets had high levels of PCV2 maternal antibodies. Groups A, B, and C
were infected with a PCV2 inoculate at d0, while group D was not infected until d42.
Pigs from group A experienced seroconversion by 42 days post infection (dpi), which
indicated the presence of PCV2 infection. Pigs from group B, which had low antibody
levels, experienced a decline in maternal antibodies by 14 dpi. By 42 dpi, four of the five
group B pigs contained PCV2 DNA. In-group C, only two of the eight pigs that
demonstrated high antibody levels demonstrated PCV2 viremia by 42 dpi. All five group
D pigs, which were inoculated at d42, were infected with PCV2. All of the pigs were
challenged again at d42 to determine the length of protection from PCV2 maternal
antibodies, and to evaluate the result of previous PCV2 exposure on piglets reinfected
with PCV2. Of the reinfected groups all were tested negative for maternal antibodies
except for group C pigs, and only two became viremic.
The results of this study indicated that levels of PCV2 maternal antibodies are an
important element for allowing piglets to mount an immune response to a PCV2
infection. Furthermore, those piglets with negative or low maternal antibody levels did
not have sufficient immune protection against PCV2 infection and became viremic, and
demonstrated seroconversion. This study suggests that there is a potential relationship
between the levels of PCV2 maternal antibodies, and the degree of immune protection,
and having a higher level of maternal antibodies results in more immune protection.
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Another study conducted by Calsamigilia and others (2007), evaluated the litter
effect in different PMWS-affected farms and observed the relation to three variables,
including, sow parity, PCV2 infectious status and sow PCV2 antibody titres. Seven farms
that demonstrated PMWS in nurseries and/or fattening areas were designated for the
experiment, and each farm randomly selected 15 sows (105 sows). After farrowing, four
piglets were selected from each sow (60 piglets per farm; 420 piglets total) and were
observed for seven months. In addition, pathological exams were performed to inspect for
symptoms characteristic of PMWS. Of the 420 initial piglets, 104 piglets died (24.8%).
Of the 104 piglets that died, 40 were diagnosed with PMWS. Thirty-eight of the 105
(36.2%) sows did not produce any piglets that died during the study period. Of these
sows, 36 (94.7%) were determined to be PCV2 PCR negative; while 2 out of 7 (28.6%)
sows that had three or four piglets die during the study period were PCV2 PCR positive.
Furthermore, 32 of these 38 (84.2%) sows had medium to high antibody titres, where
only 2 out of 7 (28.6%) sows had medium to high antibody tires. The results of this study
indicated increasing maternal antibody titres, while decreasing sow infection status could
reduce PMWS occurrence.
The objective in another study, conducted by Opriessnig and others (2004a) was
to produce PCV2 negative piglets from PCV2 positive sows. Maternal antibody decay,
transfer of maternal antibodies, and sow herd profiles were examined during the study.
The piglets produced during this study were not considered viremic. It was suggested
that perhaps passively acquired antibodies could inhibit PCV2 replication until levels of
maternal antibodies decreased; however, after the antibodies had waned, the piglets were
at risk for PCV2 infection.
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Co-infections
Pigs affected with PMWS can demonstrate a wide range of concomitant
infections, which can enhance the outcome of PCV2 infection and increase the
occurrence of PMWS in both experimental and in field conditions (Pogranichniy et al.,
2002; Rose et al., 2003; Dorr et al., 2007). In natural cases of PMWS, affected pigs
display a variety of associated infections. In a review conducted by Grau-Roma and
others (2011), eight viruses, three mycoplasmas, and three bacteria are discussed and
recognized as co-infecting agents associated with field cases of PMWS. Viral pathogens
that tend to co-infect with PCV2 include PRRSV, PPV, porcine epidemic diarrhea virus
(PEDV), Aujeszkys disease virus, Hepatitis E virus, torque teno virus (TTV), porcine
teschovirus, and swine influenza virus (SIV). PCV2 concomitant mycoplasmas include
bacterial pathogens that are found in PCV2 infected animal includes Mycoplasma
hyorhinis, Mycoplasma suis, Mycoplasma hyopneumoniae, Salmonella cholera suis,
Escherichia coli, and Haemophilus parasuis. Of these co-infecting agents, PPV (Allan et
al., 1999; Krawkowa et al., 2000), PRRSV (Allan et al., 2000b; Harms et al., 2001) and
Mycoplasma hyopneumoniae (Opriessnig et al., 2004b) are thought to stimulate PCV2
associated lesions and increase the occurrence of PMWS.
A field study conducted by Pallares and others (2001) examined field cases of
PMWS from all over North America submitted to a US diagnostic laboratory. The
objective of the study was to determine the prevalence of different pathogens and identify
which co-infecting agents are most commonly diagnosed in conjunction with PCV2. In
this study, 4,688 tissues samples were reviewed for the presence of PCV2 and PMWS.
Using immunohistochemistry, 1,751 (37%) of the submitted tissue samples, tested
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positive for PCV2. In addition, 484 (10.3%) of these samples tested positive for PMWS.
Tissue samples were submitted from North Carolina, Oklahoma, and Minnesota;
however, about 80% of the samples came from Iowa.
The most common concurrent infection was PCV2 and PRRSV with 164
occurrences, although numerous other combinations of concomitant infections were
detected as well. Other infections included PCV2 and Mycoplasma hyopneumoniae (92
cases), PCV2, PRRSV and Mycoplasma hyopneumoniae (77 cases), PCV2 and bacterial
septicemia (68 cases), PCV2 and bacterial pneumonia (37 cases) and PCV2 and SIV (13
cases). From the samples, only nine cases of singular PCV2 were detected. In the cases
demonstrating PMWS, ages were provided for 369 of the 484 samples. From these 369
samples, most of the infections occurred between 8 and 18 weeks (294 cases) with the
most common point of infection occurring at 10 weeks of age.
In 2000, a study by Krakowa examined the effects of PCV2 in conjunction with
PPV in 26 Caesarian derived gnotobiotic piglets. Experimental piglets were divided into
infection groups as follows: PCV1 singular infection (n=3), PCV2 singular infection
(n=3), PPV singular infection (n=3), PCV1 and PPV simultaneous infection (n=4), PCV2
and PPV simultaneous infection (N=4), and PCV1 and PCV2 simultaneous infection
(n=4), and control piglets (n=3). The results of this experimental infection demonstrated
that piglets receiving singular infections, and those receiving a simultaneous infection of
PCV1 and PCV2 remained clinically normal, only exhibiting minimal swelling of lymph
nodes. The effects of simultaneous infections differed significantly from singular
infections. All four piglets receiving simultaneous infections of PCV2 and PPV
developed acute gross lesions characteristic of PMWS, jaundice and subcutaneous edema
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causing necessary euthanasia on 30 dpi. In addition, three of these four pigs demonstrated
a decrease in thymus size as well as moderate histological lesions. From the piglets given
single infectious doses, none of the piglets given PPV and only 50% of piglets given
PCV1 became viremic. In this study, PCV1 was unable to produce clinical symptoms,
which confirmed that PCV2 is the primary causative agent responsible for eliciting
PMWS disease progression and is exacerbated by concurrent infections with other viral
pathogens.
In 2000, Allan and others conducted a study to understand the significance of
PRRSV infection in the development of PCVAD and explained effects of concurrent
infections of PCV2 and PRRSV on colostrum-deprived piglets. In this experiment, 3
treatments were assigned: PRRSV singular infection (n=4), PCV2 singular infection
(n=3), and PRRSV and PCV2 simultaneous infection (n=5). Pigs given singular
inoculations did not express clinical and did not develop gross lesions. Of the piglets
given simultaneous inoculations, one pig suffered enlarged lymph nodes and another pig
from the same group experienced a decrease in thymic size. In addition, four of the five
pigs given simultaneous inoculations experienced lymphoid, liver, renal, and vascular
lesions. From the three infection treatment groups, only pigs given simultaneous
inoculations expressed clinical illness. The results from this study suggest that PRRSV
infections can enhance PCV2 replication and stimulate PCVAD disease progression.
In a similar study conducted by Harms and others (2001), 59 experimental piglets
derived from ten different sows were used for experimental infection and challenged with
PRRSV and PCV2. Experimental piglets were distributed into four treatments as follows:
control (n=10), singular PCV2 inoculation (n=19), singular PRRSV inoculation (n=13),
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and concurrent PCV2 and PRRSV inoculations (n=17). The control pigs did not express
any clinical respiratory diseases. Before the study started, the singular PCV2 inoculation
treatment experienced some mortality unrelated to the treatments. One pig from died
from severe exudative epidermitis, three died from hemorrhagic gastric ulcers, and two
others were euthanized in the early stage of the study because of jaundice, and
depression.

Although pigs given a single PRRSV inoculation demonstrated acute

respiratory problems after 7dpi, no pigs from this group died or were euthanized. Pigs
given concomitant inoculations of PRRSV and PCV2 demonstrated similar respiratory
symptoms to PRRSV infected pigs; however, ten pigs contracted severe dyspnea and
depression between 10 and 20dpi. From this group, four pigs died early and six others
were euthanized on the terms of animal welfare. The other pigs in this group all died.
From this study it was observed that pigs given simultaneous inoculations of PRRSV and
PCV2 experienced more severe hepatic lesions and lymphoid depletion compared to
single PCV2 infected pigs. Furthermore, all pigs given simultaneous inoculations
developed necrotizing hepatitis and interstitial pneumonia. The results of this study are
similar with other experimental infections involving PCV2 and PRRSV, and again
suggest that PRRSV plays a role in enhancing PCV2 progression.
In another experiment performed by Opriessnig and others in (2004), 67
experimental pigs were used to investigate the relationship between Mycoplasma
hyopneumoniae and PCV2. Pigs were randomly assigned to a treatment groups as
follows: group 1- controls pigs (n=17), group 2- single M. hyopneumoniae inoculation
(n=17), group 3- dual inoculation of M. hyopneumoniae and PCV2 (n=17), and group 4single PCV2 inoculation (n=16). Pigs were inoculated at two different time points. At 4
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weeks of age, pigs were inoculated intratracheally with M. hyopneumoniae, and
intranasally with PCV2 at 6 weeks of age. Single M. hyopneumoniae and PCV2 infected
pigs demonstrated mild to moderate dyspnea, lethargy, and reduced weight gain, where
pigs given simultaneous M. hyopneumoniae and PCV2 inoculations displayed moderate
to severe signs of respiratory disease. Similar M. hyopneumoniae associated lesions were
observed in both single and simultaneous infections.
Pigs given dual inoculations and single PCV2 inoculations exhibited severe
lymph node enlargement; however, pigs given single M. hyopneumoniae inoculations did
not demonstrate the same circumstance. All of the pigs except for controls developed
interstitial pneumonia. In addition, four of the 17 simultaneous M. hyopneumoniae and
PCV2 inoculated pigs developed lesions characteristic of PMWS, though none of the
singular PCV2 inoculated pigs displayed PMWS symptoms. The results of this study
indicated that M. hyopneumoniae could play a role in boosting the effects of PCV2 and
increases PCVAD disease progression.
Pogranichniy and others (2002) preformed a field-based case-control study, to
investigate the role PCV2 and other major swine viral antigens play in the development
of PMWS. In this study, 31 pigs showing signs of PMWS and 56 controls between the
ages of 4 and 16 weeks were observed during a 6-month period. All of the pigs were
tested for numerous viruses including: PCV2, PRRSV, PPV, porcine enterovirus, SIV,
porcine respiratory coronavirus (PRCV), transmissible gastroenteritis virus (TGEV),
porcine endogenous retrovirus (PERV), porcine lymphotropic herpesvirus (PLHV) and
bovine viral diarrhea virus (BVDV). All of the pigs tested positive for PERV, the virus is
being considered omnipresent in swine. PCV2 was detected in 29 pigs of the 31 PMWS
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affected field cases (94%) and in 35 of the 56 control pigs (63%). PRRSV was also
identified in 42% of the PMWS affected field cases and 20% of the control pigs.
Statistical analysis from this study revealed that an animal infected with PCV2 is 9.3
times more likely to develop PMWS compared to pigs not infected with PCV2, and an
animal co-infected with PCV2 and PRRSV is 31.2 times more likely to develop PMWS
compared to pigs that do not have concurrent infections of PCV2 and PRRSV. The
results of this study confirm the results of previous reports indicating that the probability
of developing PMWS increases in animals infected with PCV2 and other agents such as
PRRSV or PPV.
Results of all these studies revealed that the presence of PCV2 is essential, but
several other pathogens also play a role in PCVAD development and progression

Transmission
Transmission of PCV2 can occur through several routes of exposure, including
oro-nasal, intranasal, and subcutaneous (Allan et al., 1999; Pogranichniy et al., 2000;
Bolin et al., 2001). The high prevalence of PCV2 in swine herds worldwide indicates that
PCV2 transmission is effective (Kristensen et al., 2009) and is most likely transmitted
horizontally between pigs via oro-fecal and respiratory routes (Caorioloui et al., 2006)
but can also be transmitted vertically (West et al., 1999; Ladekjær-Mikkelsen et al.,
2001). Vertical transmission occurs directly from mother to embryo, while horizontally
transmission occurs through contact with members of the same species, excluding parent
and offspring relations. For example, horizontal transmission occurs when non-infected
pigs are exposed to infected pigs (Grau-Roma et al., 2011).
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Horizontal Transmission: Several studies have demonstrated that PCV2 DNA
can be detected in nasal, tonsillar, fecal swabs (Bolin et al., 2001; Harms et al., 2001;
Shibata et al., 2003; Caprioloi et al., 2006 and Patterson et al., 2010) as well as
tracheobronchial and urinary swabs (Segalés et al., 2005). Since PCV2 is shed through
multiple routes, horizontal transmission is the most efficient method of viral proliferation
within a population. It has been demonstrated that PCV2 targets the lymphoid tissues
(Opriessnig et al., 2007) and is shed between infectious and susceptible pigs through
feces, urine, respiratory, nasal, and oral secretions (Segalés et al., 2005) and residues for
prolonged periods of time (Bolin et al., 2001). PCV2 DNA has also been detected in milk
and semen, which suggest additional potential routes of transmission (Krakowka et al.,
2000). Intranasal exposure is the most common route of natural PCV2 transmission;
however, pigs can be experimentally infected by intramuscular, intrauterine, oral, and
intranasal methods of inoculation (Madson et al., 2011; Segalés et al., 2012 and Rose et
al., 2012).
In order to understand the shedding mechanism and infection dynamics of PCV2,
Patterson and others (2010) conducted a study using 26 experimental pigs for inoculation.
Methods of inoculation included: pooled oral samples given intraperitoneal (IP), pooled
fecal samples given IP, pooled nasal samples given IP, pooled oral samples given orally,
pooled fecal samples given orally, and pooled nasal samples given intranasally (IN) and
intramuscular (IM) injections. The pigs given the three different IP inoculations
demonstrated seroconversion of anti-PCV2 antibodies and developed PCV2 viremic
conditions. Pigs given intranasal inoculations also developed PCV2 viremic conditions.
Of the four pigs given fecal samples orally, two displayed signs of infection. Of the three
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pigs given IM injections, one became viremic. Pigs given oral samples orally did not
develop PCV2 viremia. The results of this study indicate that under experimental
conditions, PCV2 is predominately shed through nasal, oral and fecal secretions.
Another study conducted by Yang and others (2003) demonstrated that PCV2
could be transmitted through feces. In this study, 97 pigs were used to extract fecal and
intestinal samples. Of the 97 pigs, 63 pigs demonstrated symptoms of enteric disease, and
the other 34 pigs showed no signs of gastrointestinal complications. Polymerase chain
reaction (PCR) was used to detect the presence of PCV2 DNA in the intestinal and fecal
samples. Of the 63 enteric diseased pigs, 18 tested positive for PCV2, where PCV2 DNA
was detected in 14 intestinal samples, and in 4 fecal samples. The results of this study
indicate that PCV2 can be successfully shed and transmitted through fecal matter.
A study performed by Andraud and others (2008) demonstrated that transmission
was more efficient when non-infected pigs were housed in the same pens as infected pigs
compared to non-infected pigs housed in separate pens. Although this study demonstrated
that PCV2 transmission occurred more frequently when non-infected pigs were housed in
the same pens as infected pigs, indirect infections can also occur even when infected and
non-infected pigs were housed in separate pens.
In a study performed by Kristensen and others (2009), 12 swine herds were used
to verify if pigs taken from PMWS-unaffected herds could develop PMWS after being
exposed to pigs from PMWS-affected herds. All of the herds tested positive for PCV2
and eight of the herds were PMWS-affected, while the other four were PMWSunaffected. Some PMWS healthy pigs shared pens with PMWS-affected pigs, while other
PMWS healthy pigs where placed in pens next to PMWS-affected pigs. Furthermore,
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some PMWS healthy pigs where also placed in pens across the aisle from PMWSaffected pigs. Of the PMWS healthy pigs, ten housed with PMWS-affected pigs, three
housed in pens neighboring PMWS-affected pigs and one housed across the aisle form
PMWS-affected pigs demonstrated clinical symptoms of PMWS. The results of this study
verified the assumption that direct and indirect exposure can induce PMWS.
Although little research has been done on PCV2 transmission from infected pork
products, some researchers have suggested the possibility of transmission through meat in
slaughter houses and packing plants. Allan and others (1994) determined that PCV2 is
stable at a pH of 3, which led to a study conducted Opreissnig and others (2009b)
demonstrating that it is likely that meat from a PCV2-postive animal could be capable of
transmission because slaughter houses and packing plants rarely reach a pH that lower
than 6.2. The United States swine industry increased the exportation rate of pork products
from 422,373 metric tons in 1996 to 1,262,499 metric tons in 2006 (Opriessnig et al.,
2009b). Pork products are exported from the United States to several countries including
Japan, South Korea, Mexico, Canada, China, and Taiwan as well as numerous other
countries. Although it is beneficial for the United States swine industry to increase the
exportation rate of pork products, it also increases the risk of transmitting diseases
between countries. Opriessnig and others conducted a study to determine if PCV2 was
transmissible through consumption of meat and bone meal. Since PCV2 has been
detected in lymphoid tissue, bone marrow (Bolin et al., 2001) and heart tissue (Kennedy
et al., 2000) understanding the relationship between oral consumption and PCV2
infection is an important piece of the transmission mechanism. The objectives of this
study were to determine if PCV2 infected pork products contained PCV2 DNA or antigen
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and if PCV2 infected pork products were capable of infection. Tissue samples derived
from three 7-week old pigs inoculated intramuscularly and intranasally with PCV2. The
three pigs were euthanized at 14dpi and tissue samples were collected including skeletal
muscle, spleen, tonsil, lymph nodes, and bone marrow from three previously infected
pigs. Then fifteen 2-week old colostrum-deprived crossbred pigs were randomly assigned
to five treatment groups each in a different room. The treatment groups were as follows:
group 1- controls (n=3), group 2- skeletal muscle given orally (n=3), group 3 bone
marrow given orally (n=3), group 4lymphiod tissue given orally (n=3), group 5 PCV2
inoculum via stomach tube (n=3). Pigs given skeletal muscle, bone marrow, or lymphoid
tissue developed viremic conditions after 7dpi. In addition, all of the pigs in the study
became PCV2 positive and microscopic lesions from lymphocytic depletion were
developed in nine of the fifteen experimental pigs. The results of this study indicate that
PCV2 infection can be transmitted through uncooked skeletal muscle, bone marrow, and
lymphoid tissue via oral consumption.
The results from all of these studies demonstrate that PCV2 horizontal
transmission can occur through a wide range of secretions and excretions as well as
consumption and can be detected in numerous regions of the body.
Vertical Transmission From Infected Sows: Although breeding females under
field conditions can be infected with PCV2, sows typically demonstrate subclinical
infections and do not display clinical symptoms (Madson et al., 2011). However, if sows
become viremic during pregnancy, PCV2 can spread across the placenta and infect
fetuses. Vertical transmission, which occurs directly from dam or sire to embryo has been
supported by numerous studies. Natural PCV2 infection in pregnant sows can result in
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late term abortions as well as increases the mortality in live-born piglets (Calsamiglia et
al., 2007). Sows that have been given PCV2 vaccinations can protect their offspring
through passive immunity. In a study performed by Tomás and others (2008) involving a
PCV2 experimental infection observed that piglets that did not receive colostrum had a
higher incidence of PMWS. In addition, Calsamiglia and others (2007) demonstrated that
piglets produced from sows with low maternal antibody titres had higher rates of
mortality compared to piglets produced from sows with higher levels of maternal
antibodies. In a review paper written by Grau-Roma and others in 2011, demonstrated
that sows with higher PCV2 viremia had increased piglet mortality rates.
Preceding studies have described an occurrence known as the “litter effect” which
involves high mortality in post-weaning multisystemic wasting syndrome (PMWS)
affected farms. In order to examine the litter effect, Calsamiglia and others (2007)
conducted a study to evaluate litter mortality in different PMWS affected farms and to
further characterize its relation to sow parity, PCV2 infectious state and PCV2 antibody
titres. The present study was performed in seven farms that demonstrated PMWS in
nurseries and/or fattening areas. From each farm 15 sows were randomly selected for the
experiment (105 sows). Once the sows had farrowed, four piglets were randomly selected
from each sow (60 piglets per farm; 420 piglets total). The 420 selected pigs were
observed for a seven-month period where pathological exams were routinely performed
to evaluate the development of PMWS. Of the total number of piglets used in the
experiment 104 piglets died (24.8%) and 40 (38.5%) were diagnosed with PMWS.
Because mortality due to PMWS infection is associated with sow PCV2 viremia, the
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results of this study suggest that sow infection status around farrowing, plays a significant
role in the pathogenesis of the disease progression on a litter.
It has recently been demonstrated that transplacental transmission of PCV2 can
occur from infected pregnant sows (Park et al., 2005). In a study performed eight
pregnant sows, serologically negative for PCV2, PPV, and PPRSV were used for
experimental infection. Each sow was randomly assigned to either a PCV2 infected
(n=6) or control (n=2) group. The sows assigned to the PCV2 infection group were
infected three weeks prior to the expected farrowing date via intranasal inoculations
containing 6 ml of tissue culture fluid (1.2 x 105 TCID50/ml) of an isolated PCV2 strain
(SNUVR000473). Of the experimental sows used in this study, all six aborted before 21
dpi, producing 65 stillborn and 10 liveborn piglets. In contrast, both PCV2-negative
control sows remained clinically healthy and demonstrated normal gestations delivering
17 liveborn piglets at 114 days of gestation. In addition, the piglets delivered from control
sows did not express presence of PCV2. Of the tissue samples tested, the results suggest
that PCV2 travels to lymphoid tissues from the placenta via the bloodstream and
predominantly replicates in these tissues in prenatal fetuses.
The results from this study indicate that PCV2 is capable of inducing reproductive
failure in pregnant sows. Previous studies have demonstrated that PCV2 is detectable in
aborted fetuses at all stages of gestation (Kim et al 2004b) and is able to replicate in
fetuses after intra-fetal inoculation at any stage of gestation (Sanchez et al., 2001). The
combination of results from preceding experiments, as well as the present study strongly
denotes that PCV2 is capable of crossing the placenta at any stage of gestation.
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The results from these previous studies suggest that sows challenged with PCV2
under experimental conditions as well as sows experiencing natural PCV2 infection have
an increase in the number of stillborn and mummified fetuses (Park et al., 2005) and that
aborted fetuses from pregnant sows can express PCV2 antigen in the myocardium (West
et al., 1999).
Once PCV2 infection occurs, shedding of the virus can occur via bodily fluids
(Ha et al., 2009). In a study performed by Ha and others, colostrum and milk from PCV2
infected sows were evaluated for the presence of PCV2. Pregnant sows were randomly
selected and assigned to a PCV2 infected (n=6) or a control (n=2) group. Sows from the
infected group were inoculated intranasally at 93 days of gestation, with an isolated
PCV2 strain (SNUVR000470). In addition all of the sows from both groups remained
clinically normal, without farrowing prematurely and delivered liveborn pigs between
114 and 115 days of gestation. Colostrum samples were collected from all eight sows
immediately after farrowing. Milk samples were also collected at 1, 3, 6, 9, 12, 15, 18,
21, 24, and 27 days of lactation from all eight sows.
Of the colostrum samples taken from each infected sow, all six milk whey and
pellet samples were positive for PCV2 via PCR. In addition, both of the colostrum
samples taken from control pigs were negative for PCV2 via PCR. Of the milk samples
taken from each infected sow, all six milk whey samples were positive for PCV2 via PCR
from day 3 lactation until day 27; however only three of the pellet samples were positive
for PCV2 via PCR at 3 days lactation. From the control sows, all milk whey and pellet
samples for both colostrum and milk were negative for PCV2 for all time periods of
lactation. Previous studies have reported that PCV2 viremic sows and low PCV2
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antibody titres in infected sows are associated with piglet mortality (Calsamiglia et al.,
2007). The results of the present study support these preceding studies and indicate that
PCV2 DNA is shed in both colostrum and milk from experimentally infected pregnant
sows causing an increase in piglet mortality.
Vertical Transmission From Infected Fetuses: Fetuses derived from sows
infected intranasally with PCV2, have detectable amounts of PCV2 DNA and antigen
present in lymphoid tissues, myocardial tissues, and other organs, which indicate PCV2
replication (Park et al., 2005). In stillborn and mummified fetuses, PCV2 antigen has also
been detected in myocardial tissues and tonsils (Madson et al., 2009). It appears that
PCV2 predominately targets myocardial tissues for replication in stillborn and
mummified fetuses, which can cause vasculitis and cardiac failure.
Vertical Transmission From Infected Boars: Numerous reports have detected
PCV2 DNA in semen from infected boars (Larochelle et al., 2000; Kim et al., 2003a;
McIntosh et al., 2006 and Madson et al., 2008); therefore, several experiments have been
conducted to determine if PCV2 infected semen can be infectious to piglets.
A study led by Larochelle and others, determined that PCV2 can be shed in semen
from infected boars. In this study, 4 boars were house in isolated pens, and infected
intranasally with PCV2 isolate LHVA-V53. Semen and serum samples were routinely
collected to evaluate the presence of PCV2. The results of this experiment demonstrated
that all 4 boars shed PCV2 DNA in their semen. Although it was not determined if the
PCV2 was infectious, the authors indicated the need for follow up studies to conclude the
infectious state of PCV2 DNA shed through semen (Larochelle et al., 2000).
PCV2 DNA has been found in testes and accessory glands of infected boars
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(Opriessnig et al, 2006). The shedding period for PCV2 in semen from experimentally or
naturally infected boars can occur from 6 days (Madson et al., 2008) to 27 weeks
(McIntosh et al., 2006). Reproductive failure can be experimentally induced by
artificially inseminating naïve sows with PCV2 infected semen (Madson et al., 2009).
In another study conducted by Madson and others (2009), PCV2-free sows were
artificially inseminated with PCV2-spiked semen to try to induce infection. Nine specificpathogen-free (SPF) sows were broken into three groups. Group 1 sows were negative
controls and were artificially inseminated with PCV2-negative semen, group 2 sows were
artificially inseminated with semen containing PCV2a, and group 3 sows were artificially
inseminated with semen containing PCV2b. The three sows given PCV2a semen failed to
maintain pregnancy, therefore no pigs were born live, stillborn, or mummified. The three
sows artificially inseminated with semen containing PCV2b produced 35 piglets. Of these
piglets, only 8 were born alive, 2 were stillborn, and 25 were mummified. The stillborn
piglets developed lesions due to myocardial dysfunction and cardiac dilation. In addition,
all live-born, stillborn and mummified fetuses demonstrated detectable PCV2 antigen in
myocardial tissue indicating that myocardial tissue is the preferred target for PCV2
replication in fetuses. The results of this study suggest that PCV2-spiked semen can
induce viremic conditions in the sow and stimulate intrauterine infections causing
viremia in fetuses and should therefore be considered for PCV2 transmission (Madson et
al., 2009).
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Porcine Circovirus Associated Diseases
PCV2 infection may result in the progression of several distinct syndromes and
disease including post-weaning multisystemic wasting syndrome (PMWS), porcine
dermatitis and nephropathy syndrome (PDNS), porcine reproductive failure, porcine
respiratory complex, and PCV2-associated enteritis. The wide spectrum of clinical
manifestations is problematic for developing strategies for PCV2 diagnosis and
prevention, and presents a difficult challenge for researchers such as veterinarians,
pathologists, virologists, and epidemiologists (Chae, 2005).
Post-weaning Multisystemic Wasting Syndrome: Post-weaning multisystemic
wasting syndrome (PMWS) was first discovered in Canada in 1991(Gagnon et al., 2007);
however, occurrences have also been detected worldwide (Chae, 2005). Although Canada
first recognized PMWS as a newly emerging disease in 1996 causing wasting in postweaned pigs, it is currently recognized as a disease worldwide (Chae, 2005). PCV2 has
been identified as the etiologic agent responsible for causing PMWS (Allan et al., 1998a;
Ellis et al., 1998; Hamel et al., 1998). Numerous PMWS outbreaks have been reported
from swine herds from major pig producing areas in the world such as North and South
America, Europe, and Asia (Chae, 2004), which has caused major economic concern. In
addition, PMWS occurs in both endemic and epidemic forms in Asia and Europe.
PMWS is typically observed in pigs that are between 25 and 120 days of age, with
the highest number of cases occurring between 60 and 80 days of age (Chae, 2004).
Characteristic symptoms of the syndrome include weight loss, dyspnea, jaundice,
enlarged lymph nodes, hepatocyte necrosis, multifocal lymphohistiocytic pneumonia,
lymphocyte depletion, and multinucleated giant cell formation (Harding, 1997 and
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Gagnon et al., 2008). PMWS-affected pigs will also experience a reduction in circulating
lymphocytes causing a decline in immunological function (Takahagi et al., 2009), though
only 10-30% of naturally PCV2 infections progress into PMWS (Darwich et al., 2004).
In addition, lesions consisting of clusters of globular intracytoplasmic inclusion
bodies are characteristic of PMWS (Sorden 2000). Other lymphoid lesions can be
identified in numerous tissues in affected animals such as tonsils, Peyer’s patch, spleen,
thymus, and lymph nodes (Darwich et al., 2004). Although these lesions are indicative of
PMWS, not all affected animals will demonstrate theses lesions; therefore there are other
methods that can determine if a PCV2 infection will progress into PMWS. For example,
during necropsy PMWS-affected pigs can exhibit lungs that are tan in color, kidneys may
have white stripes or spots, and enlargement of lymph nodes (Gillespie et al., 2009).
PMWS can also alter the cytokine balance and expression in affected pigs.
PMWS stimulates and upregulation of several cytokines including interleukin 10 (IL-10)
and interferons such (interferon-gamma) INF-γ. The over-production of IL-10 in the
thymus, can lead to atrophy of the thymus, and thymic depletion. In addition, PMWS can
elicit the over-production of INF-γ in the tonsils (Darwich et al, 2003).
In a study performed by Darwich and others in 2003, to analyze the cytokine
expression patterns in different lymphoid tissues lymphoid tissues in naturally PCV2infected, PMWS-affected pigs. During the study, 10 eight-week old PCV2 positive pigs
showing characteristic signs of PMWS and 5 healthy control pigs were used for the data
collection. Blood samples and lymphoid samples were taken from each animal to
correlate the cytokine expression pattern with haematological and histopathological
results. Of the ten PCV2 positive PWMS-affected pigs, 3 had severe thymic depletion
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and atrophy. The other 7 PCV2 positive PWMS-affected pigs demonstrated enlarged
lymph nodes, interstitial pneumonia and lymphoplasmacytic hepatitis. The histological
lesions observed in the 10 PCV2 positive PWMS-affected pigs displayed mild to severe
lymphocyte depletion.
PWMS-affected pigs demonstrated a cytokine mRNA expression alteration of
several important cytokines involved in driving a specific immune response in different
organs being examined (Darwich et al. 2003). These cytokines include IL-12, IL-10, IL2, IL-4 and INF-γ. From the cytokine imbalance, IL-10 was notably over expressed in the
thymus as well as a decrease in expression of IL-2 and IL-12 in the spleen. IL-10 plays a
role in anti-inflammatory effects and regulates natural killer and B-cell growth. The over
expression of IL-10 in the thymus could be responsible for the origin of T-cell depletion,
which could have significant effects on T-cell function. IL-10 upregulation also suggests
the presence of an active immune stressor. IL-2 and IL-12 are known as T-cellstimulating factors. IL-2 is involved in the growth and proliferation of T cells and IL-12
plays a role in the differentiation of naïve T-cells into Th1 cells. The results from this
study indicate that the increased levels of IL-10 mRNA as well as the overall cytokine
imbalance could be involved with T-cell immunosuppression.
PMWS is known as a multifactorial syndrome. PCV2 infection is necessary for
the development of PMWS, though singular PCV2 infection is not sufficient enough to
elicit PMWS progression (Calsamiglia et al., 2007). Development of PMWS is dependent
upon several factors such as sow immune status, herd management, co-infections, and
virulence of the infecting strain.
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In order to diagnosis PWMS, three criteria must be met: (i) clinical signs must be
expressed, such as weight loss, dyspnea, jaundice, and wasting (ii) PCV2-characteristic
microscopic lesions must be present, including lymphoid depletion or histiocytic
replacement of follicles in lymphoid tissues and (iii) PCV2 antigen or nucleic acid must
be present within lesions (Chae, 2004 and Sorden 2000). All three criteria must be met in
order to establish PMWS diagnosis; therefore, detection of PCV2 alone does not suggest
PMWS, instead just a PCV2 infection. To determine diagnosis, immunohistochemistry
and in situ hybridization techniques are used to link virus and tissue lesions (Chae, 2004).
To establish an accurate diagnosis of PMWS, lymphoid tissues such as spleen,
tonsil and thymus as well as pancreas, liver, lung and kidney tissues should be collected
for testing. In a study led by Opriessnig and others in 2004, a specific scoring system was
developed to evaluate the extent of PCV2 infection in seven types of lymphoid tissues.
Each lymphoid tissue was given a score ranging from 0 to 9, where the scoring system
evaluated each tissue based on three categories including lymphoid depletion (0 to 3),
granulomatous inflammation (0 to 3), and PCV2-immunohistocehimstry (0 to 3).
Although they scoring system was subjective, it enabled a consistent evaluation of each
tissue affected from infection.
Cases of PMWS have been reported in all types of swine operations including
farrow-to-feeder, farrow-to-finish, off-site nursery, and grower pig farms. Small
operations with as little as 50 sows as well as larger operations with up to 1200 sows
have reported PMWS signs (Harding and Clark 1997). Therefore, it appears that every
herd can potential experience PMWS. Since most PCV2 infections involve co-infections,
it has been suggested that various pathogens could potentially utilize the same
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mechanisms as PCV2 to evade the immune system. In addition, simultaneous infections
of PCV2 with other viruses such as porcine reproductive and respiratory syndrome virus
(PRRSV), porcine papovirus (PPV) can exacerbate the condition of the infected animal
(Krakowka et al., 2000). Therefore it has also been proposed that PCV2 infections may
potential play a role in increasing host susceptibility to other pathogens.
PCV2-associated Enteritis: Although incidences of PCV2-associated enteritis
occur less frequently compared to other PCV2-associated syndromes and diseases, it can
have detrimental effects on many systems of the body. Affected pigs become heavily
diarrheic and experience inflammation of the large intestine as well as decreased weight
gains (Kim et al., 2004a). Younger pigs are more vulnerable and are typically affected
between 40 and 70 days of age (Chae, 2005).
Diagnosis of PCV2-associated enteritis is based on three criteria: (i) presence of
diarrhea, (ii) presence of characteristic microscopic lesions in the Peyer’s patches but not
in the lymph node, and (iii) presence of PCV2 within these lesions (Kim et al., 2004a;
Chae, 2005). Because PCV2-associated enteritis symptoms are clinically and
histologically similar to PMWS, accurate diagnosis is difficult. Therefore, lesions present
in the Peyer’s patches but absent in lymph nodes is indicative of PCV2-associated
enteritis, while lesions present in the lymph nodes suggest PMWS (Kim et al., 2004a).
Porcine Respiratory Disease Complex: Another PCV2 associated disease, which
causes severe health issues in growing and finishing pigs is porcine respiratory disease
complex (PRDC). Pigs who are clinically affected are typically between 16 to 22 weeks
of age, and show signs of slow growth, low feed efficiency, anorexia, fever, cough, and
dyspnea (Halbur, 1998b; Thacker, 2001). Pneumonia can also be seen in pigs affected
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with PRDC, which is caused from a combination of both viral and bacterial agents (Kim
et al. 2003b). The co-infecting viral agents include PCV2, PPV, PRRSV and SIV and coinfecting bacterial agents include Mycoplasma hyopneumoniae, Actinobacillus
pleuropneumoniae and Pasteurella multicida (Halbur, 1998b; Thacker, 2001).
Symptoms seen in PRDC-affected pigs are similar to those observed in PMWSaffected pigs; however, PRDC affects older pigs typically between 16 and 22 weeks of
age, where PMWS affects younger pigs at about 8 to 16 weeks of age. Pigs affected with
PRDC due to PCV2 infections usually express widespread granulomatous inflammation,
and intracytoplasmic basophilic viral inclusion bodies (Kim et al., 2003b). In addition,
PCV2 also causes lesions associated with bronchointerstitial pneumonia (Chae, 2005).
Accurate diagnosis of PRDC is based on four criteria: (i) the presence of respiratory
signs, (ii) the presence of characteristic pulmonary microscopic lesions, (iii) the presence
of PCV2 within these lesions, and (iv) the absence of the characteristic lesions associated
with PMWS in the lymphoid tissues (Chae, 2005).
Porcine-associated Reproductive Failure: PCV2 has the potential to infect
pregnant sows, which can induce abortion and cause fetal deaths (Park et al., 2005).
Porcine-associated reproductive failure was first reported in Canada in 1999 (West et al.,
1999). Gilts in start up operations are typically affected with porcine-associated
reproductive failure and show clinical signs of increased abortion, still births, delivery of
fetal mummies, and increased mortality in pre-weaning piglets (West et al., 1999;
Ladekjaer-Mikkelsen et al., 2001; O’Connor et al., 2001; Kim et al., 2004b; Gillespie et
al., 2009). In a review paper conducted by Chae in 2005, several previous studies are
discussed indicate that sows infected with PCV2 had higher incidences of stillborn and

46
premature piglets. PCV2-associated reproduction failure can occur through all stages of
gestation, which can be problematic for swine producers (Sanchez et al., 2001).
In addition, PCV2 DNA has been detected in the testes as well as accessory
glands of infected boars (Opriessnig et al, 2006), which indicates the potential to induce
reproductive failure can be induced by artificially inseminating naïve sows with infected
boars (Madson et al., 2009). A study led by Kim and others in 2004, tested 350
aborted/stillborn fetuses for presence of PCV2, PPV, and PRRSV (Kim et al., 2004b).
The aborted/stillborn fetuses were collected from 321 Korean farms. Of 350 fetuses, 43%
tested positive for one of the three viruses. In addition, 10% of the fetuses tested positive
for a singular infection of PCV2. The results of this study suggest that PCV2 could
potentially induce reproductive failure (Kim et al., 2004b).
Another study performed by O’Connor and others in 2001 described an acute
reproductive failure outbreak at a farm consisting of 3,000 sows. During an 8-week
period, the number of mummified fetuses increased to 15%, as well as the number of
stillborns, which increased to 8% and the rate of pre-weaning mortality rose to 11%
(O’Connor et al., 2001). Tissue samples were taken from two stillborn fetuses and two
piglets, which died shortly after birth, were evaluated for the presence of PCV2. Of the
four samples, PCV2 was detected in the heart of two of the piglets, as well as in the lung
and spleen tissues in the other two piglets. The results from this study reveal that PCV2
can be transmitted vertically, inducing PCV2 infection in piglets in utero.
Porcine Dermatitis and Nephropathy Syndrome: The first incidence of porcine
dermatitis and nephropathy syndrome (PDNS) was identified in the United Kingdom in
1993 (Smith et al., 1993; White and Higgins, 1993; Gillespie et al., 2009). Since the
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original discovery, PDNS has also been recognized in numerous swine producing
countries (Drolet et al., 1999). Although the disease typically affects nursery and grower
pigs and is often fatal (Opriessnig et al., 2007), PDNS has also been seen in finishing pigs
and replacement gilts (Chae et al., 2005). The most predominate indication of PDNS;
particularly in the acute phase of the disease is the development of red and purple skin
lesions located on limbs and abdomen and hindquarters (Drolet et al., 1999; Harding,
2004; Gillespie et al., 2009). Other characteristic signs seen in PDNS-affected pigs
include fever, weight loss, lethargy, as well as loss of appetite. PDNS-affected pigs can
also experience edema including enlarged, pale kidneys, enlarged lymph nodes, and
gastric ulcerations (Droplet et al, 1999). Pigs experiencing severe cases of PDNS can also
exhibit stiff gait or reluctance to move, rapid, dyspnea or tachypnea (Drolet et al., 1999).
Farms that observe severe anorexia, weight loss, and skin lesions typically experience
higher mortality rates. A review conduced by Drolet and others in 1999 suggest that
PDNS is a vascular disease that emulates other immune-mediated disorders to induce
acute inflammation. Although PCV2 was first reported in association with PDNS in 2000
(Rosell et al., 2000), previous research from 1990 indicates that swine herds from
Northern Ireland experiencing cases of PDNS exhibited granulomatous lymphadenitis
associated with PCV2 antigen in affected pigs (Allan et al., 2000c).
Wellenberg and others led a case-control study in the Netherlands to investigate
the role of PCV2 in the development of PDNS. In this study, 3 PDNS-affected pigs were
selected from 10 different Dutch swine herds (n=30). The selected pigs displayed
symptoms including lethargy, fever, as well as red and purple skin lesions located on the
abdomen and limbs. Several pigs demonstrated enlarged grey-brown kidneys with white
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spots on the renal cortex in addition to hemorrhagic lymph nodes during necropsy
examinations. The authors of this study were not able to identify PCV2 via
immunohistochemistry (IHC); however, using PCR amplification, all of pigs tested
positive for the presence of PCV2, 33% pigs tested positive for the presence of PPV, and
83% tested positive for the presence of PRRSV. In addition, PDNS-affected and nonaffected pigs were evaluated for the presence of anti-PCV2 antibodies. The results of this
study indicated that there is a significant association between the level of anti-PCV2
antibody titres and the development of PDNS (Wellenberg et al., 2004).
In another study, Sipos and others (2005) evaluated the systemic cytokine patterns
in 5 PDNS-affected pigs, 5 PMWS-affected pigs, and 5 control pigs to increase the
understanding of PDNS pathogenesis. PDNS-affected pigs demonstrated an upregulation
in the expression of interleukin 1α (IL-1α), interleukin 6 (IL-6), interleukin 10(IL-10),
and interferon gamma (INF-γ) compared to control pigs. In addition, PDNS-affected pigs
experienced a downregulation in interleukin 2 (IL-2), interleukin 4 (IL-4) compared to
control pigs. Although the results of this study are indicative of proinflammatory
conditions, more research is necessary to gain a more complete understanding of PDNS
pathogenesis (Sipos et al., 2005).

PCV2 Diagnosis
Clinical symptoms of an acute PCV2 infection occur in a variety of forms.
Several symptoms such as weight loss, paleness of skin, respiratory difficulty, and
diarrhea are characteristic indicators of PCV2 infections, but require further investigation
for a precise diagnosis. Other indications can be observed upon necropsy such as
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lymphocyte depletion, inflammation of lymphoid tissues, granulomatous, and detectable
levels of PCV2 in damaged tissues. Currently the most accurate method diagnosing an
acute PCV2 infection is to evaluate the severity of clinical symptoms.
Although characteristic manifestations of porcine circoviruses associated diseases
(PCVAD) such as PMWS, PDNS, and PRDC, are usually obvious and can easily be
identified, laboratory procedures produce the most definite diagnosis.
Laboratory techniques such as immunohistochemistry (IHC) and in situ
hybridization (ISH) are used to detect PCV2 in selected tissue samples. IHC is used to
detect specific antigens in cells of selected tissue by combining immunological,
histological, and biochemical techniques using a specific antigen/antibody reaction
tagged with a visible label. IHC uses polyclonal and monoclonal antibodies to identify
the presence of PCV2 antigen. ISH is a type of hybridization procedure used to identify
the location of DNA or RNA sequences in selected tissue
Serological tests are typically used for large-scale PCV2 diagnosis. Because
certain pigs can be seropositive, but do not demonstrate clinical symptoms of PCVAD,
gaining an accurate diagnosis can be problematic. For accurate diagnosis serological tests
should be performed at the herd level and not on individual pigs. Therefore number of
pigs being evaluated should be considered when conducting serological tests (Gillespie et
al., 2009). Quantitative real-time PCR (qPCR) is another method used for detecting
PCV2. This procedure is based off of traditional PCR and is used to amplify a targeted
DNA; however qPCR also quantifies the level of targeted DNA present in the sample.

50
Diagnostic accuracy is the essential component for treating viral infections
appropriately. In addition, early diagnosis of PCV2 infections is crucial in preventing
clinical outbreaks and maintaining a healthy swine herd.

PCV2 prevention and Control
Mortality due to PCVAD significantly impacts the global swine industry. PCV2 is
an economically important pathogen because of its infectious capability, which has the
potential to infect herd populations. In addition, the wide variety and severity of PCV2
symptoms also complicates treatment options. Currently there is no specific treatment
available for PCV2 infections as well as any of the PCV2-associated diseases.
Factors such as PCV2 isolates, co-infections, immune stimulation, as well as host
susceptibility play a crucial role in disease progression; consequently accurate prognosis
is dependent upon these influential factors. For instance, a large number of PCV2
infections involve co-infections; therefore prognosis is also dependent upon accurate
identification of other pathogenic agents infecting the animal.
Prevention can be challenging since disease outbreaks have been reported in
farms with strict management practices. Vaccinating for co-infecting agents can help
reduce the spread of PCV2; however, many co-infecting agents exist further complicating
this prevention method. Good herd management techniques are essential for disease
prevention. These management techniques can include reducing stress, minimizing the
mixing/sorting of pigs, cleaning and disinfecting barns, keeping buildings at the optimal
temperature for size and age of pig, decreasing humidity in barns, maintaining optimal air
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quality via proper ventilation, reducing overstocking of pens, as well as supporting proper
animal hygiene (Harding et al, 2004; Gillespie et al., 2009).
In a review conducted in 2007, Opriessnig and others discussed several methods
such as disinfection to reducing viral replication and PCV2 outbreaks. Chemicals such as
sodium hydroxide, Virkon S (Antec International, UK), Roccal D Plus (Parmacia and
Upjohn, US), Clorox Bleach (Clorox Company, US), and Tex-Trol (Bio-Tek Industries
Inc, US) have demonstrated a reduction in the spread of PCV2 in laboratory settings;
though, these chemical disinfectants have not yet been tested in commercial settings.
In addition, Madec and others developed a 20-point plan to reduce the impact of
PCV2. The most effective preventative measure is assuring good management techniques
that minimize stress, eliminate co-infections that trigger PCV2 infection to progress to
PCV2-associated disease. In order to maintain a healthy herd, at least the first 16 points
should be adopted into typical swine management techniques to ensure the most effective
viral prevention (Madec et al., 1999).

PCV2 Vaccinations
It is imperative to note that PCV2 is the primary causative agent responsible for
stimulating the development of PCVAD; however, several studies have demonstrated that
the use of vaccines has a significant impact in growing pigs (Horlen et al., 2008;
Fachinger et al., 2008; Kixmoller et al., 2008; Opriessnig et al., 2009; Neumann et al.,
2009). A study conducted by Jacela and others (2011) demonstrated a significant increase
(P< 0.001) in growth performance in vaccinated pigs compared to control individuals.
The results of this study, provides significant evidence that the use of PCV2 vaccines has
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a significant impact on growth rates in feeder pigs, and is useful in controlling the
development of PCVAD.
Current PCV2 vaccines include Ingelvac® CircoFLEX™, Porcilis® PCV,
Suvaxyn PCV2® One Dose, Circumvent PCV ™, and Circovac®. The outer capsid
proteins of PCV2, which are encoded in open-reading frame 2 (ORF2) appear to be
highly immunogenic and are therefore the most antigenically significant component of
the vaccine (Burch, 2008). Both Ingelvac® CircoFLEX™ (Boehringer Ingelheim), and
Porcilis® PCV (Schering-Plough/ Intervet) are capsid based vaccines. Ingelvac®
CircoFLEX™ is a PCV2 subunit vaccine that uses capsid proteins as antigens and killed
baculovirus vectors to prevent PCV2 viremia and shedding (Boehringer Ingelheim). In
order to produce the antigen for the vaccine, the ORF2 gene encoding the PCV2 capsid
protein is placed into the baculovirus vector, which is injected into the host. Using this
vaccine can be very beneficial to swine producers because it is a single-dose vaccine
requiring 1 ml injected intramuscularly, which reduces the stress on the pig as well as
decreases the labor/production costs. In addition, this vaccine can be administered in
healthy pigs as early as 3 weeks of age providing early and sustained immunity
(Boehringer Ingelheim).
Porcilis® PCV is another subunit vaccine, which uses PCV2 capsid proteins to
stimulate the immune system and diluvac tocopherol as an adjuvant (Burch, 2008). This
vaccine can be given to pigs as early as 3 weeks of age; however, it requires 2 doses,
which increases stress on the animal as well as potentially increase production costs.
Circumvent G2® is similar to Ingelvac® CircoFLEX™, and uses an inactivated
baculovirus vector to prevent against PCV2 viremia and shedding. There are many
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advantages to using this vaccine because it offers a wide range of dosing options.
Currently Circumvent G2® is the only PCV2 vaccine approved to use in pigs as early as
3 days of age. In addition, this vaccine can be administered in one or two dose methods,
which allows the producer to choose which dosing program would best fit their operation.
The one dose method requires a 2 ml intramuscular injection, which is recommended for
pigs that are exposed to PCV2 after 7 weeks of age, and if the co-infection disease
pressure is low (Intervet). This is beneficial to the producer because labor is a limiting
factor, and this reduces stress to the animal. The two-dose method requires an initial 1 ml
intramuscular injection as early as 3 days of age, and a second 1 ml dose 3 weeks later.
This method is recommended for pigs that are exposed to PCV2 before 7 weeks of age
and offers optimal best immunity (Intervet). This method should be used if the coinfection disease pressure is high. In addition, Merck has also implemented Circumvent
PCV-M G2, which is currently the only 1-dose, single-bottle, combo vaccine for PCV2
and mycoplasmal pneumonia (Merck).
Suvaxyn PCV2®One Dose is a killed-recombinant vector vaccine, which uses an
inactivated PCV1-2 chimera antigen (Burch, 2008), to prevent PCV2 viremia and reduce
PCV2 –associated lymphoid depletion. Recombinant vector vaccines are similar to
subunit vector vaccines; however they use attenuated viruses or bacterium to introduce
viral DNA to cells of the body. This vaccine is marketed by Fort Dodge® Animal Health
and can be administered in one dose using 2 ml in healthy pigs 4 weeks or older which
reduces the stress on the pig as well as reduce the labor/production costs (Burch, 2008).
Circovac® is produced by Merial, and is used for sows and gilts and to provide
passive protection/immunity to offspring via colostrum. Production of the vaccine
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involves an inactivated PCV2 virus to produce the antigenic component and mineral oil
as the adjuvant. Sows vaccinated with Circovac®, experienced a reduction in PCV2
circulation and shedding in piglets (Charreyre et al., 2005). In addition, these piglets
demonstrated improved health during an experimental infection at 3-4 weeks of age
(Charreyre et al., 2005). Although this vaccine is proven to be effective, it is also labor
intensive because it requires two doses of 2 ml given 3 to 4 weeks apart before mating.
In addition, this vaccine program requires a booster to be given every gestation period.
Several studies have been conducted to determine the effectiveness of various
vaccines. A study conducted by Lyoo and others (2011) tested the effectiveness of
Circumvent PCV ™, Ingelvac® CircoFLEX™, and Suvaxyn PCV2® One Dose. In this
study, 4 pigs were randomly selected per 20 different litters (n=80). Of the 4 pigs per
litter, 3 were randomly assigned vaccines and 1 was designated as a control. Vaccines
were administered via protocols directed from their respective companies. The three
different vaccine groups fluctuated in average daily gain (ADG). Pigs that were given
Circumvent PCV ™, and Ingelvac® CircoFLEX™ experienced higher overall ADG
compared to the control pigs (P<0.05). Viremia was relatively low in the vaccinated pigs.
For instance only 15.2 % of pigs given Suvaxyn PCV2® One Dose, 16.9% of pigs given
Circumvent PCV ™, and 18.1% of pigs given Ingelvac® CircoFLEX™ tested positive
for PCV2 DNA, compared to 27.5% observed in controls. Although PCV2 DNA was
detected in vaccinated animals, no clinical symptoms were observed.
Takahagi and others (2009) conducted a study to evaluate the effects of using two
commercially available vaccines (Ingelvac® CircoFLEX™ and Porcilis® PCV) in
Japanese commercial pig farms demonstrating PCV2 infections. A total of 997 pigs were
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randomly selected and assigned to one of three groups: (i) Porcilis® PCV vaccinated
group, (ii) Ingelvac® CircoFLEX™ vaccinated group, and (iii) a control group. At 24
week, the mortality rate for the vaccinated pigs was 11% for the Porcilis® PCV
vaccinated group, and 13% for the Ingelvac® CircoFLEX™ vaccinated group, compared
to 32% observed in the control group. The results of this study reveal that using
Porcilis® PCV and Ingelvac® CircoFLEX™ resulted in a reduction in mortality.
Research has demonstrated that PCV2 vaccination can have a minimizing effect
on ADG, mortality rates, as well as PCV2 viremia and shedding. This suggests that
PCV2 vaccination is a practical possibility for reducing the PCVAD incidences and
should be implemented into common swine management techniques.

Genetic Parameters Used For Selection
Currently there is no prevention method that is entirely secure in protecting
against PCV2 infections; however, recent research has suggested the potential to select
animals that are less susceptible to PCV2 infections. Bates and others (2008) evaluated
the genetic and environmental effects that influence variation in PCVAD. In this study,
3,271 pigs from two genetic lines known for reproductive and growth traits were
evaluated for PCVAD symptoms. Each pig was given a score from 0 to 2, based on
PCVAD symptoms such as wasting, respiratory difficulty, decreased growth, and
diarrhea. A score of 0 indicated no symptoms and signified that the pig was normal. A
score of 1 denoted minor symptoms and indicated potential PCVAD progression. A score
of 2 was given if the pig demonstrated obvious characteristic symptoms of PCV2
infection. All pigs that were given a score of 2 were humanely euthanized and were
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evaluated during necropsy. In addition, immunohistochemistry and real-time PCR was
also performed for each evaluation. Of the 3,271 pigs, 41 experienced co-infections with
M. hyopneumoniae (n=19), Streptococcus suis (n=18), and Lawsonia intracellularis
(n=4).
The PCVAD scores for each pig were compared to birth weight, weaning weight,
weight at d65, and weight at d180 to estimate correlations and heritabilities. Moderate
correlations were found between PCVAD score and birth weight (r=0.34, P< 0.10) as
well as PCVAD score and weight at d65 (r=-0.53, P< 0.01). Heritabilities were moderate
for PCVAD score (0.16+/- 0.04), and weaning weight (0.16 +/- 0.06), birth weight (0.27
+/- 0.07), and both weight at d65 and at d180 (0.23 +/-0.06). Heritability estimates were
larger at d90 compared to d125 for viremia (0.38 +/- 0.11 vs. 0.11 +/- 0.08) and IgG
antibody titres (0.55 +/- 0.21 vs. 0.10 +/- 0.08).
The results from this study suggest that immune response to PCV2 is heritable;
therefore genetic selection in herds where PCV2 is prevalent could be a potential method
to decrease PCV2 infections. Although PCV2 vaccinations have an effect on ADG,
mortality rates, as well as PCV2 viremia and shedding, they increase production and
labor costs. Selecting animals that appear to have less susceptibility to PCV2 could be a
potential alternative to vaccinations and even be used as a complementary tool in cases
where extra protection is needed.

Summary
Porcine circovirus type 2 (PCV2) is the major causative agent responsible for
inducing the development of PCVAD. In addition, PCV2 is an economically important
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pathogen because it is environmentally stable and its infectious capability has the
potential to infect large populations. As the global population increases, the demand for
meat also rises indicating a need for healthier pork production. Therefore, pigs with
increased resistance to PCVAD and other diseases will play an essential role in the future
of pork production worldwide.
Although the PCV2 pathology is not completely clear, vaccines have proven
successful in the prevention of PCV2 outbreaks and have an effect on ADG, mortality
rates, as well as PCV2 viremia and shedding. Previous research has demonstrated that
breed differences influences susceptibility and plays a role in PCVAD progression,
suggesting that genetic selection may be the next step for reducing the incidences of
PCVAD. Selection based on DNA markers associated with PCVAD resistance has the
potential to decrease economic losses, improve animal welfare and provide alternatives to
vaccination.
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CHAPTER 2: Phenotypic Variation of the Indicators of PCVAD Susceptibility in
Experimental Infection with PCV2b

2.1 INTRODUCTION

In order to improve productivity, economic efficiency and animal welfare in
swine operations, proper control and prevention of infectious diseases is crucial. Porcine
circovirus 2 (PCV2) has been identified as the etiological mediator responsible for
stimulating the progression of a multifactorial disease known as porcine circoviruses
associated diseases (PCVAD), which exhibits a variety of symptoms. PCVAD
encompasses several diseases including post-weaning multisystemic wasting syndrome
(PMWS), PCV2-associated enteritis, porcine respiratory disease complex (PRDC),
PCV2-associated reproductive failure, and porcine dermatitis and nephropathy syndrome
(PDNS). PCV2 is an economically important pathogen because its virulent aptitude has
the capability of infecting large populations, which significantly impacts production
efficiency of the global swine industry (Opriessnig et al., 2006).
PMWS appears to be the most frequently occurring PCV2-associated disease and
is characterized by wasting in weaned pigs, dyspnea, diarrhea, and lymphoid depletion
(Allan et al., 2000; Opriessnig et al., 2006). Swine operations suffering PMWS outbreaks
typically experience high mortality. Pigs affected with PCV2-associated enteritis
demonstrate diarrhea, decreased weight gains, and inflammation of the large intestine
(Kim et al., 2004). Pigs affected with porcine respiratory disease complex (PRDC) show
signs of decreased growth, low feed efficiency, anorexia, fever, cough, and dyspnea
(Halbur, 1998b; Thacker, 2001). Sows suffering from PCV2-associated reproductive
failure typically experience abortion, as well as increased delivery of stillbirths, and fetal
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mummies (Kim et al., 2004; Gillespie et al., 2009). Porcine dermatitis and nephropathy
syndrome (PDNS) involves the development of red and purple skin lesions on limbs and
abdomen (Drolet et al., 1999; Harding, 2004) and typically affects nursery and grower
pigs (Opriessnig et al., 2007).
Several studies have demonstrated that vaccinations are the most effective method
of PCV2 prevention and control (Takahagi et al., 2009). In order to successfully reduce
the effects on ADG, mortality rates, as well as PCV2 viremia and shedding, every pig in
the system must be vaccinated. Swine operations that employ vaccinations into their
herd-management program will experience a decrease in PCV2 infections; however, it
increases production cost, especially when the number of vaccination solutions and novel
pathogens continues to increase.
Previous research has suggested that Landrace pigs are more susceptible to
PCVAD compared to other breeds such as Large White, Yorkshire, Duroc or Pietrain,
which indicates that variation in host genetics plays a role in PCVAD susceptibility
(Zhou et al., 2006; Opriessnig et al., 2006; Opriessnig et al., 2009). Therefore, using host
genetics to select for PCVAD resistance in the nucleus population could be an alternative
and/or complementary method to vaccination and have the potential to reduce production
costs.
The following research investigates the phenotypic variation in response to
experimental challenge with PCV2b in various crossbred populations. The data collected
during the experimental challenge was used to evaluate the difference between individual
responses to infection. The objective of this research was to assess phenotypic variation
of important indicators of PCV2 susceptibility. Gaining a better understanding of the

76
immunosuppressive role of PCV2 and factors that influence the development of PCVAD
will provide essential information regarding the swine immune system, benefiting the
global swine industry.
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2.2 MATERIALS AND METHODS

Experimental Design: Animals, Diets, and Housing
The experimental procedures used during this study were reviewed and approved
by the Institutional Animal Care and Use Committee of the University of NebraskaLincoln (UNL). The pigs used for the experimental challenge were distributed over time
in nine batches (B1 to B9) ranging from 81 to 141 pigs per batch. Barrows were used in
all of the batches except B2 and B3, which consisted of both barrows and gilts.
A total of 974 experimental pigs produced from 320 litters with 3.04 pigs per
litter were provided from two resources including the UNL Swine Research Unit, and
members of the PigGen Canada Consortium. The UNL Swine Research Unit produced
maternal and terminal crossbred pigs for batches 1 through 4 (n=386) and members of the
PigGen Canada Consortium provided maternal crossbred pigs for batches 5 through 9
(n=588). The structure of the resource population can be seen in Table 1.
The pigs produced by The UNL Swine Research Unit involved three major breeds
including Large White, Landrace, and Duroc of commercial origin as well as the
Nebraska Index Line, which has been selected since 1981 mainly for traits related to litter
size. The pigs provided by members of the PigGen Canada Consortium involved two
major breeds including Large White (dams), and Landrace (sires). Further description of
the breeding systems for each resource batch can be seen in Table 2.
All experimental pigs were colostrum fed and raised under similar conditions.
Before experimental infections, each pig was evaluated and tested negative for the
presence of PCV2. Furthermore, each pig was also tested for levels of IgG and IgM
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PCV2 specific antibodies. Pigs used for the experimental infection had to show a
sample/positive ratio (S/P) lower than 0.3 for passive IgG maternal antibodies and lower
than 0.4 for IgM (McKnite et al., 2014). This was an essential aspect of the selection
process because the S/P thresholds were used to assess the level of IgG maternal
antibodies (passive) as well as determine if pigs were actively infected (IgM) or had
experienced previous PCV2 exposure (host IgG). High levels of passive antibodies were
associated with reduced susceptibility to PCVAD (McKeown et al., 2005). Any pig that
demonstrated S/P threshold values that exceeded the limit was culled from the selection
pool. Pigs that demonstrated negligible S/P levels and tested negative for PCV2 were
transferred to the UNL Animal Science Complex for the experimental challenge.
Throughout the experimental infection, pigs were housed in one experimental
room containing 24 identical pens. Pigs were randomly assigned to a pen, which
consisted of both slatted and solid surface flooring. Each pen provided approximately
0.65 square meters of floor space per pig. The diet used involved a standard balanced diet
that met or exceeded nutritional requirements (NRC, 1998) and was fed ad libitum. Upon
arrival at UNL facilities, each pig received a preventative dose of 0.8 ml of Baytril® 100
for any unaccounted bacterial pathogens.

PCV2b Isolate and Experimental Infection
The PCV2b strain used for the experimental infection was isolated from a pig
with characteristic PCV2 symptoms. The sequence of the experimental strain belongs to
the PCV2b cluster from Quebec (Canada) and is highly similar to strain FMV-05-6507,
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which is known to induce clinical signs of PMWS as well as produce high mortality rates.
The strain was cultured in swine testicular lines as described in McKnite et al. (2014).
Experimental pigs were inoculated with a titer of 104.0 TCID50/ml of the PCV2b
strain both intranasally and intramuscularly. The average age of infection across all
batches was 43 days of age. Daily observations were conducted during the 28-day
experimental period to monitor and detect clinical symptoms. In addition, weight and
blood samples were collected a 0, 7, 14, 21, and 28 days post infection (dpi).

PCV2 Sequencing
PCV2b viral isolation was performed using QIAamp DNBA Minikit (Qiagen).
Two primer sets including Forward 1: GCAGCACCTCAGCAGCAA, Reverse 1:
TCCTCCGTGGATTGTTCTGTAGC, Forward 2: TTTTGCAGACCCGGAAACCA,
and Reverse 2: CAGCGCACTTCTTTCGTTTTCA along with Go Taq Flexi DNA
Polymerase (Promega) were used for amplifying the viral genome. After amplification,
the PCR products were then purified using ExoSAP-IT (USB Corporation). The
experimental strain was sequenced from both directions using dye terminators using ABI
PRISM 3100 Genetic Analyzer (Applied Biosystems) and aligned to PCV2 DNA
sequences available in GenBank using ClustalW2 (Larkin et al., 2007). In addition, after
the experimental challenge, random viral DNA samples from all batches were amplified
and sequenced under the same procedures to validate the PCV2 strain of the PCV2b
strain used for experimental infection.
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Serology
Blood samples were collected in sterile 7 ml Monoject Red Stopper Blood
Collection Tubes containing no additives (item # 8881301413 Tiger Medical, Irvington,
NJ, USA). The blood was then equally separated into 7.5 ml BD Vacutainer tubes
(Reference # 367987, Franklin Lakes, New Jersey, USA) and 7.5 ml Tempus Blood RNA
tubes (Reference # 4342792 Life Technologies, Carlsbad, California). The tempus blood
RNA collection tubes contain a RNA stabilizing solution (Applied Biosystems Carlsbad,
California, USA). Once all of the blood samples were collected, the tempus blood RNA
collection tubes were placed in a -20°C freezer for storage and the BD Vacutainer tubes
were immediately centrifuged at 3500 rotations per minute (rpm) for 15 minutes at 4°C.
After centrifugation, the serum was poured into a 2.0 ml tube and placed in a -20°C
freezer for storage.

PCV2 Specific Antibodies
Enzyme-linked immunosorbent assay (ELISA)(Ingenasa, Madrid, Spain) was
used to evaluate the levels of PCV2 specific antibodies such as IgG and IgM in serum.
Samples exhibiting a S/P ratios greater than 0.4 were considered to be positive for IgG,
and S/P ratios greater than 0.3 were considered to be positive for IgM. The levels of
PCV2 specific antibodies were normalized based on positive control values.

Viral DNA Quantification
Viremia or estimates of viral copy counts in blood were also measured for each
pig. Viral DNA was first isolated from serum samples using QIAamp DNA Minikits
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(Qiagen, Valencia, California, USA) and was then quantified by conducting quantitative
real-time PCR (qPCR) using TaqMan Master Mix and ABI 7900 Real Time PCR System
(Applied biosystems). Area under the curve (AUC) was used to evaluate the total viral
load for each pig throughout the entire experimental challenge period. Viral load was
calculated for each pig using an algorithm based on viremia levels determined at each
time point (0, 7, 14, 21, and 28 dpi) to fit a smooth curve over the 28 day infection period
and summed the areas in increments of 0.01 time units (Boddicker et al., 2012).

DNA Isolation and Genotyping
Ear notch samples were taken from each pig for DNA isolation. DNeasy or
Puregene tissue kits (Qiagen, Valencia, California, USA) were used for the DNA
extraction. DNA extracts were assessed using a NanoDrop Spectrophotometer (Thermo
Scientific, Wilmington, Delaware, USA) as well as agarose gel electrophoresis for DNA
quantity and quality. DNA extracts were used for genotyping as described in chapter 3.

Statistical Analysis
Pair-wise correlations between residuals were estimated based on a linear mixed
model treating batch as a fixed effect, age at infection and passive IgG levels as
covariates, as well as litter and pen as random effects. The means and measures of
variability were estimated for each trait across time points, as seen in Table 3.
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2.3 RESULTS AND DISCUSSION

Immune Response in Growing Pigs
Although PCV2 is classified as a pluripotent virus, it predominately replicates in
epithelial and endothelial cells (Steiner et al., 2008). PCV2 also inhibits the function of
Natural Interferon Producing Cells (NIPC) also known as plasmacytoid dendritic cells
(pDC), which play a critical role in the innate immune response. These NIPC/pDC are
associated with the secretion of several pro-inflammatory and anti-viral cytokines
including tumor necrosis factor-α (TNFα), and type I Interferons, (IFNs), which are
involved with anti-viral immunity. PCV2 inhibits the function of NIPC/pDC by
preventing the stimulation of interferon- α (IFNα) and TNFα involved in the maturation
of myeloid dendritic cells, which secrete interleukin 12 (IL-12) to assist with T cell
differentiation. The process of T cell differentiation is crucial for anti-viral immunity and
recognition of bacterial and viral pathogens. Inhibition of this process leads to secondary
infections (Vincent et al., 2005) and can severely impact growth performance. Therefore,
swine operations use vaccines to decrease the progression of PCVAD. Several studies
have provided substantial evidence, indicating that the use of PCV2 vaccines is useful in
controlling the development of PCVAD (Horlen et al., 2008; Fachinger et al., 2008;
Kixmoller et al., 2008; Opriessnig et al., 2009; Neumann et al., 2009).

Growth Rate During Experimental Infection with PCV2b
The viral strain used for the experimental infections was isolated from a pig
demonstrating characteristic signs of PCVAD and similar in DNA sequence to a
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Canadian cluster of strains known to induce PCVAD and increase mortality rates (e.g.,
FMV-05-6507)(Gagnon et al., 2007; Carmen et al., 2008). Differences in PCV2 virulence
in both experimental and natural infection have been demonstrated in previous research
(Opriessnig et al., 2006; Opriessnig et al., 2008).
Differences in ADG between weeks following experimental infection showed a
decrease in rate of ADG occurred during the third week, compared to the other weeks.
The mean weekly ADG can be seen in the Figure 1. The most variation observed in ADG
occurred between 21 (x 0.48, σ = 0.25), and 28 dpi (x 0. 8, σ = 0.28). The results of
this analysis can be seen in Table 3.

Real-time PCV2 Quantification
Blood samples were collected throughout the challenge at 0, 7, 14, 21, and 28 dpi
and evaluated for the levels of circulating virus. Real-time quantitative PCR was used to
measure the number of viral copy counts in each experimental pig. The levels of
circulating virus began to increase at day 7, and peaked at day 14, followed by a decline.
The results of this analysis can be seen in Figure 2. The immune response patterns
observed during this challenge were similar to the results in other studies (Pensaert et al.,
2004; Opriessnig et al., 2004; Opriessnig et al., 2006). The most variation observed in
weekly viremia measures occurred at 14 dpi (x

3.64, σ = 1.24). In addition, the

variation for viral load was high (x 68.8, σ = 24.7). The results of this analysis can be
seen in Table 3.
Pair-wise correlations of residuals were conducted between viremia measures and
average daily gain during (ADG) infection. Moderate negative correlations were
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observed between viremia at 14, 21, and 28 dpi and ADG from 14-21, 21-28, and 0-28
dpi (r= -0.30 to-0.39; P < 0.001). The largest estimate between weekly viremia measures
and ADG was detected between viremia at day 21 and ADG between days 14-21 (r=0.39, P<0.001). The results of this analysis can be seen in Table 4. In addition, a
moderate negative correlation was detected between viral load and overall ADG (r=-0.36,
P<0.001). The results of this analysis can also be seen in Table 4. In addition, the largest
estimate for viral load was detected at ADG from 21-28 dpi (r=0.39, P<0.001). No
significant relationships were detected between ADG prior to infection with viremia
during the first two weeks of the challenge (r= 0.01 to 0.03, P> 0.63) or viral load (r= 0.02, P= 0.73) (McKnite et al., 2014). This indicates that there is a negative correlation
between viral load and ADG, which can be seen in Figure 3. Therefore viremia and viral
load are the best predictors for ADG decline following infection.
Slow growth may be a consequence of an animal’s inability to clear the virus as a
result of a weak immune system, which increases the possibility of acquiring a secondary
infection. A study conducted by Meerts and others (2005) indicated that levels of PCV2
viremia influenced susceptibility to post-weaning multisystemic wasting syndrome
(PMWS) in both natural and experimental PCV2 infections. In this study, animals with
high viremia had increased susceptibility where animals with less viremia were not as
vulnerable.

Variation in Immune Response in PCV2b-Challenged Pigs
Prior to experimental infection, all pigs demonstrated a S/P less than 0.4 for IgG,
less than 0.3 for IgM, and negative to PCV2, which indicates no current or previous
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PCV2 exposure or PCV2 vaccination, indicating that all pigs were PCV2 negative. The
levels of PCV2 specific antibodies were normalized based on positive control values.
Previous reports indicate that most PCV2 infected pigs demonstrate subclinical
symptoms in both natural and experimental infections because antibodies produced by
the humoral immune response and other unexplained mechanisms are able to clear the
virus (Meerts et al., 2005). Of the antibody isotypes (IgA, IgD, IgE, IgG, and IgM), IgG
and IgM are responsible for the main anti-viral immunity against invading pathogens.
IgG is secreted as a monomer and is the only antibody capable of crossing the placenta,
providing passive immunity from the dam to the fetus (Pier et al., 2004). Colostrum
contains high levels of IgG and IgA to provide immediate immunity to offspring. IgG
responds later to the site of infection, but is the primary antibody associated with antiviral immunity against invading pathogens (Pier et al., 2004). IgM functions in two
forms. It can either be expressed on the surface of B cells in a monomeric form or
secreted in a pentameric form. IgM is produced immediately after exposure and
eradicates any invading pathogens in the initial stages of humoral immune response
before necessary levels of IgG are produced (Pier et al., 2004). IgM has very high avidity
and indicates acute infections.
IgG and IgM levels were comparable with previous studies across the measured
time points 0, 7, 14, 21, and 28 dpi (Opriessnig et al., 2006; Opriessnig et al., 2008), and
can be seen in Figure 4. IgM levels were detectable before IgG, which was expected,
again confirming that none of the experimental pigs had been previously exposed to
PCV2. The variation in IgM immune response appeared in two main groups: early
responders and late responders, delayed by one week approximately. IgM titres in early
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responders began to increase at 7 dpi, and peaked at 14 dpi followed by a waning period.
In the late responders, IgM titres began to increase at 14 dpi, and peaked at 21 dpi
followed by slow declining titres. IgM antibody response for each pig can be seen in
Figure 5.
IgG titres started to increase in most experimental pigs at 14 dpi, peaking between
21 and 28 dpi. IgG antibody response for each pig can be seen in Figure 6.
IgG is primarily associated with the neutralizing capacity (r= 0.85, P< 0.001) (Fort et al.,
2007); therefore high titres of IgG indicate exposure to PCV2. In a study conducted by
Meerts and others, decreased levels of neutralizing antibodies resulted in an increase in
PCV2 viral replication and progression of PMWS (Meerts et al., 2006).
The most variation observed in antibody titres occurred at 28 dpi for IgG (x
2.23, σ = 0.95) and 21 dpi for IgM (x 1.64, σ = 0.68). The results of this analysis can be
seen in Table 3.
The results from the analysis of IgG and IgM titres across time points
demonstrates that immune response varies in the magnitude and in the induction of the
humoral response to PCV2b in experimental pigs. The variations followed a similar trend
in viremia.
Pair-wise correlations between IgG/IgM and average daily gain (ADG) were
relatively low and are listed in Table 5. In addition, moderate pair-wise correlations were
observed between IgG at 21 and 28 dpi and overall viremia (0-28 dpi) (r= 0.026 to 0.27;
P < 0.0001 ) as well as between IgM at 21 and 28 dpi and overall viremia (0-28 dpi) (r=
0.32; P < 0.0001 ). These correlations are listed in Table 6.
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All pigs receiving colostrum obtain antibodies that provide early immunity
against PCV2 and other pathogens. The effectiveness is dependent upon the rate at of
antibody decline, which typically occurs between 5-18 weeks (Opriessnig et al., 2009).
Previous studies have demonstrated an association between titres of passive (maternal)
IgG antibodies and the extent of protection against PCV2 (McKeown et al., 2005). For
instance, low IgG titres are associated with an increased number of PCV2 positive pigs,
where high IgG titres are associated with lower numbers of PCV2 positive pigs.
Understanding the influence of PCV2 specific antibodies on disease progression may
eventually become a trait used by producers for genetic selection of PCV2 resistant pigs.
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2.4 CONCLUSIONS

There are numerous challenges in developing management programs to prevent
PCV2 infections. Because the virus is exceptionally stable, disinfecting is difficult. In
addition, PCV2 is present worldwide, and nearly every swine operation in the United
States has already been exposed to the virus. The fact that PCV2 is extremely stable and
is present globally creates opportunities for viral transmission, making it challenging to
produce specific-pathogen-free animals. The use of vaccines has proven successful;
however, every pig in the swine system needs to be vaccinated for efficient protection,
which significantly increases the cost of production. In addition, every pig needs to be
closely monitored for signs of infection, which can be problematic because many infected
pigs experience subclinical infections and do not express visible symptoms. Therefore
routine antibody profiling using diagnostic tests such as ELISA are required to detect
PCV2 infections, which also increases production cost due to labor as well as increases
stress to the animals.
These results based on experimental infection with PCV2b determined a
substantial variation in the initiation and magnitude of both viremia as well as the
humoral immune response based on IgG and IgM antibody titres across all batches of
pigs. The mechanism of how certain pigs inhibit viral replication is not well understood,
and further research is needed to gain a better understanding of the role of host genetics
in response to infection.
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CHAPTER 3: Genomic Analysis of The Main Indicators of Susceptibility
3.1 INTRODUCTION

Genetic selection has been used to improve production efficiency in the swine
industry for many years. The main traits used in swine selection were carcass traits, such
as back fat, and loin eye area, performance traits including average daily gain, feed
efficiency, and days to 120kg, as well as reproductive traits including number born alive,
number weaned, litter size, and reproductive longevity (Tart et al., 2013).
The United States is one of the world’s most predominant pork producing
countries, ranking second in the quantity of pork products imported and exported. As the
global population increases, the demand for pork rises, indicating a need for improved
production efficiency (USDA). Therefore using genetic selection to improved production
performance will become an essential method for meeting consumer demands.
Traditional selection traits are useful for improving production efficiency in healthy pigs;
however, pathogen exposure is one the main factors preventing swine operations from
experiencing the full benefit of genetic gains. In this study, the difference in phenotype
expression in experimental challenge with a viral pathogen between experimental pigs of
different origin emphasizes the role of host genetics in disease susceptibility. For
example, potential genetic differences across experimental animals at loci involved in
immune response could suggest that certain pigs were more capable of inhibiting viral
replication, whereas others were not as effective at combating the infection. For this
reason, selection for pigs with reduced susceptibility to pathogenic exposure could be a
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practical method for improving disease resistance, and has been suggested for developing
increased PCVAD resistance in pigs (Bates et al., 2008).
In order to effectively select animals with reduced pathogenic vulnerability, a
panel of reliable DNA markers is crucial to predict individual immune response.
Conducing experimental infections using infectious porcine pathogens is required to
identify associated DNA markers to be used for assembly of this panel.
The objective of the present study was to identify genetic variants and genes that
impact individual immune response and influence PCVAD susceptibility. In this study,
various crossbred lines were challenged with a PCV2b strain similar to a cluster of
PCV2b strains known to induce clinical signs of PCVAD and increase mortality rates.
Viremia, immune response and ADG were measured weekly; all animals were genotyped
with a 60K SNP panel and genome-wide association analyses were employed. This study
provides the baseline for analyzing genomic indicators of PCV2 susceptibility.
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3.2 MATERIALS AND METHODS

Genotyping
Ear notch samples were taken from each experimental pig for DNA isolation and
genotyping. DNA was extracted using either DNeasy or Puregene blood and tissue kit
(Qiagen). DNA products were evaluated for quantity and quality using NanoDrop
Spectrophotometer (Thermo Scientific) and agarose gel electrophoresis.
Each experimental pig was genotyped using the first or second generation Porcine
SNP60K BeadArray (Illumina, San Diego, California), which included 62,183 SNPs for
the first generation and 61,565 SNPs for the second generation. Of the common SNPs,
91.6% (61,177) were mapped to the reference sequence for the porcine genome using
Build 10.2. To remove low quality DNA samples and SNP assays, a minimum GenCall
genotype quality score of 0.40 and a genotyping call rate of 0.80 were used (Tart et al.,
2013). Therefore, the genome-wide association analyses included 56,433 SNPs to profile
each of the 974 experimental pigs.

Sequence Analysis
DQB1 and DRB1, candidate genes located in the SLA II region were amplified
using genomic DNA from selected animals for high and low viral load using Go Taq
Flexi DNA Polymerase (Promega) and sequenced using dye terminators and ABI PRISM
3100 Genetic Analyzer (Applied Biosystems). DNA sequences were aligned using
Sequencher (Gene Codes) software for polymorphism discovery.
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Statistical Analysis
The GenSel software package (Fernando and Garrick, 2008) was used to estimate
the proportion of phenotypic variance for ADG, immune response and viremia explained
by high-density SNP genotypes using a Bayes B model (Kizilkaya et al., 2010). The
model used for this analysis included litter, pen, and batch as fixed effects and were
designated as class variables. In addition, the levels of passive IgG and age at infection,
which were considered to be covariates.
A genome-wide association study utilizing 56,433 SNPs was preformed using a
Bayes B model (Kizilkaya et al., 2010) with pen, batch and litter as class variables, and
passive IgG titers at day 0 and age at infection as covariates. The model included a π
value of 0.99 assuming that 99% of the SNPs have no effect on the phenotypic variance
and was run for 41,000 iterations, discarding the first 1,000 samples as burn in. In
addition, the effects from every 40th iteration were used to produce the posterior
distribution for the genetic variance, which was used to determine the probability of each
window having an effect greater than 0 or having an effect greater than the average 1 Mb
window (Tart et al., 2013). Genetic and residual variances were estimated and modified
based on similar literature results because sire effects were not included in the model.
Individual genotypes and SNP effects were used to estimate genomic prediction values as
described by Fernando and Garrick (2008).
Individual genotypes and SNP effects were used to estimate genomic prediction
values for each pig as described by Fernando and Garrick (2008). Comparing pair-wise
correlations of genomic prediction values across traits was used for the evaluation of
potential common sources of variation.
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In addition, single-marker associations between genotypes of a subset of SNPs
and phenotypic traits were evaluated using JMP 10.0 (SAS Inst. Inc.) and a linear mixed
model treating batch and SNP genotype as fixed effects, age at infection and passive IgG
titres at day 0 as covariates, as well as litter and pen as random effects. The effect of the
number of favorable alleles was estimated with a linear mixed model treating batch and
the number of favorable alleles across two SNPs as fixed, age at infection and passive
IgG titres at day 0 as covariates, and both litter and pen as random effects.

Gene Ontology/ Positional Candidate Gene Approach
The 1 Mb windows associated with the most significant differences in viral load
and ADG were extended by 1 Mb in both directions to further distinguish possible
candidate sources. Build 10.2 Sus scrofa assembly and Ensembl Genes 70 database and
BioMart data-mining platform (http://uswest.ensembl.org/biomart/martview) were used
to uncover possible swine candidate genes based on human orthologs.
The development of gene ontology terms (GO BP FAT) and pathway analysis
based on human orthologs was performed using DAVID (http://david.abcc.ncifcrf.gov/),
to further characterize possible candidate sources.
The ontology terms include 3 domains such as cellular component, biological process,
and molecular function. The cellular component refers to the location in a cell or the
extracellular environment where the gene product is active. The biological process refers
to the molecular events affected by the gene product and the relevance to the functioning
of cells, tissues, organs, and organisms. The molecular function, describes the
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biochemical activities of a gene product such as enzyme, transporter, and ligand (The
Gene Ontology Consortium et al., 2000).
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3.3 RESULTS AND DISCUSSION

Proportion of Phenotypic Variance Explained By SNPs
In general, an increase in viremia and immune response was characterized not
only by an increase in phenotypic variation but also by an increase in the proportion of
the phenotypic variation explained by SNPs. The proportion of phenotypic variance
explained by SNP genotypes for viremia measurements expressed moderate percentages
ranging from 19%, detected at 7 dpi to 52%, detected at 14 dpi. In addition, 64 % of the
variation for viral load over 0-28 dpi was explained by 60K genotypes as seen in Table 7.
The proportion of the variance observed in IgM immune response explained by SNP
variants ranged from 14% detected at 7 dpi to 60% detected at 14 dpi, while IgG immune
response ranged from 3% detected at 7dpi to 44% dpi detected at 21 dpi. The impact of
the SNP genotypes on the variation in ADG was generally weak ranging from 7%
detected between days 14 – 21 and 21-28 dpi, to 13% detected between 0 – 7 dpi. The
overall proportion of variance for ADG was 16%.

PCV2 Viremia: The results from conducting a genome-wide association study
(GWAS) using a Bayes B model revealed two major SNPs, ALGA0110477 and
ALGA0039710, which explained 11.5% and 2.8% of the genetic variation for viral load as
seen in Figure 7. The location of ALGA0110477 is positioned at the proximal end of
SSC12 at 3.66 Mb based on linkage disequilibrium estimates (r > 0.32 with SNP
ALGA0122316). The location of ALGA0039710 is positioned within a region of the swine
genome known as the Swine Leukocyte Antigen II (SLA II) complex, which is one of
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the most gene-dense regions in the swine genome involved in immune response (Lunney
et al., 2009). Genes located in this region are important determinants in immune response
to pathogens (Lunney et al., 2009). The SLA complex is highly polymorphic and consists
of three major clusters (class I, II, and III) that span chromosome 7. The coding regions
of two of the genes located in the SLA II region, DQB1 and DRB1 were sequenced in
experimental pigs selected for both high and low levels of viral load.
By analyzing genetic variation explained by 1 Mb windows, we found that the 1
Mb window located at the proximal end of SSC12 and the window located at SSC 7
together explained 18.5% of the genetic variation. ALGA0110477 and ALGA0039710
explained more than 94% of the genetic variance associated with their respective
windows. The first ranked 1 Mb window containing ALGA0110477 is located at the
proximal end of SSC12 and explains 10.5% of the additive genetic variance for viral
load. The probability of the effect explained by this window being significantly greater
than zero and also greater than the average genetic variance explained by the 1 Mb
windows was greater than 0.99. The second ranked 1 Mb window containing
ALGA0039710 is located on SSC7 and explains 7.7% of the additive genetic variance for
viral load. The probability of the effect explained by this window having an effect greater
than zero and greater than the average genetic variance explained by 1 Mb windows was
greater than 0.90.
The proportion of phenotypic variance for weekly viremia explained by SNPs
ranged between 19% to 52%, with the greatest contributions detected at 14 (52%) and 21
dpi (45%) as seen in Table 7. The top windows for viremia at 14 dpi were located at SSC
7 (25 Mb), SSC 7 (28 Mb) and SSC 7 (24 Mb) and explain approximately 10.99% of the
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genetic variance. Analysis of single DNA marker effects showed that after the top 3
SNPs located in the SLA I (ASGA0031928, SSC7, 25.1 Mb) and SLAII regions
(INRA0024482, SSC7, 29.6 Mb; ALGA0039710, SSC7, 28.9 Mb) the forth SNP was
ranked ALGA0110477 (SSC12), associated with the largest individual effect on viral
load. The top windows for viremia at 21 dpi were located at SSC 7 (28 Mb), SSC 7 (29
Mb) and SSC 6 (126 Mb) and explain approximately 12.97 % of the genetic variance.
The windows located at 28, 29 Mb overlap SLA II complex of genes.

PCV2 IgM and IgG: The proportion of phenotypic variance for IgM explained
by SNPs ranged between 14% to 60%, with the greatest contributions detected at 14
(60%) and 21 dpi (44%) as seen in Table 7. The top windows for IgM at 14 dpi were
located at SSC 19 (39 Mb), SSC 12 (3 Mb) and SSC 12 (31 Mb) and explained
approximately 0.76 % of the genetic variance. The top windows for IgM at 21 dpi were
located at SSC 5 (86 Mb), SSC 6 (9 Mb) SSC 14 (25 Mb) and explained approximately
1.48 % of the genetic variance. The top windows for IgM at 28 dpi were located at SSC
15 (151 Mb), SSC 1 (251 Mb) SSC 5 (87 Mb) and explain approximately 2.29 % of the
genetic variance.
The proportion of phenotypic variance for IgG explained by SNPs ranged
between 3% to 44%, with the greatest contributions detected at 21 (44%) and 28 (38%)
dpi as seen in Table 7. The top windows for IgG at 21 dpi were located at SSC 11 (11
Mb), SSC 4 (81 Mb) and SSC 8 (72 Mb) and explained approximately 1.35 % of the
genetic variance. The top windows for IgG at 28 dpi were located at SSC 14 (135 Mb),
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SSC 10 (59 Mb) and SSC 6 (119 Mb) and explained approximately 1.17 % of the genetic
variance.
PCV2 Average Daily Gain: The proportion of phenotypic variance for weekly
ADG explained by SNPs was limited ranging between 7% to 16%. The largest proportion
of phenotypic variance for ADG was for overall ADG measured between 0 to 28 dpi and
was 16% as seen in Table 7. The top windows for ADG between 0 and 28 dpi were
located at SSC 1 (137 Mb), SSC 14 (31 Mb) and SSC 18 (3 Mb) and explain
approximately 1.44 % of the genetic variance.

Genetic Relationships Between Indicators of PCVAD Susceptibility
Correlations of genomic prediction values were conducted between weekly
viremia and ADG measures during infection. Moderate correlations were observed
between viremia measures at 21, and 28 dpi and ADG at 14, 21, and 28 dpi (r=- 0.11 to 0.33, P< 0.001). The largest estimate was detected between viremia at 21 dpi and ADG
between 14-21 dpi (r= -0.33). The results of this analysis indicate that viremia is the best
predictor for ADG decline during experimental infection. The results can be seen in
Table 8.

SLAII Haplotypes
Sequencing analysis of DQB1 and DRB1 in individuals with extreme values for
viral load showed SLAII haplotype distributions similar with those previously reported
(Ho et al., 2010; https://www.ebi.ac.uk/ipd/mhc/sla). For example, of the 10 haplotypes
identified based on DQB1 sequences, haplotype 701 was the most frequent, and was
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present in 28% of the selected animals. The haplotypes were constructed using 55 SNPs
detected by sequencing of DQB1 comparing the haplotypes with the sequences available
on Immuno Polymorphism Database (https://www.ebi.ac.uk/ipd/mhc/sla). Of the
animals selected for low viral load, haplotype 701 was the most frequent (36%). Of the
animals selected for high viral load, haplotype 701 (20%) and 901 (20%) were the most
common. The observed haplotypes are listed in table 9.

Pleiotropic Effect on Viremia, ADG, and Immune Response
Pair-wise correlations between genomic prediction values (GPV) generated from
Bayesian analyses indicated that common loci potentially influence the variation across
traits especially on viremia and ADG. The strongest correlations discovered occurred
between viremia detected at 21 dpi and ADG between days 14–21 dpi, and 21-28, and 028 dpi (r = -0.27 to -0.33, P< 0.0001).
These relationships and potential pleiotropic loci that influence viremia, immune
response and ADG were demonstrated by single-marker association studies for the SNPs
that following Bayes analyses displayed the largest effects - ALGA0110477 and
ALGA0039710. For example, the favorable genotype CC for ALGA0110477 was
associated with the lowest viral load (58.6) and with the highest ADG (0.50 kg)
compared to the CT (67.3, P< 0.0001; 0.47 kg, P< 0.05) and TT (74.0, P< 0.0001; 0.45
kg, P< 0.001) genotypes. Experimental animals with the CC genotype also experienced
lower IgM titres detected at day 14, 21, and 28 dpi as well as lower IgG titres detected at
21 and 28 dpi compared to CT (P<0.05) and TT (P< 0.0001). These associations indicate
that regions on SSC12 and SSC7 containing these DNA markers have an effect on the
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relationship between viremia and ADG as well as between viremia and immune response.
Within each experimental batch, the frequency for the favorable allele ranged from 0.36
and 0.68.

Effect of Favorable Alleles on Viremia, Immune Response, and ADG
The number of favorable alleles of the two SNPS located at SSC7 and SSC12 had
a large impact on the levels of viremia, immune response, and growth. Animals that
contained four favorable alleles experienced the lowest viremia levels, lowest levels of
IgM and IgG, and the highest ADG, where animals with one favorable alleles
demonstrated the highest viremia levels, highest IgM and IgG levels, and the lowest
ADG. These results can be seen in Figures 8-11. These effects appear to be additive
across the number of favorable classes.
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3.4 CONCLUSIONS

The variance in phenotype expression between experimental pigs in this study
implies the role of genetic components in disease susceptibility. Genetic differences
between experimental animals indicates that certain pigs were more efficient in reducing
viral replication, initiating an effective immune response and clearing the virus faster
compared to others.
Using genome-wide association analyses to identify important genetic variants in
experimentally infected pigs, a significant variation in host genetics involved in viremia,
ADG, and immune response was discovered. Two major SNPs were identified that
explain 11.5% (ALGA0110477) and 2.8% (ALGA0039710) of the genetic variation
responsible for viral load. ALGA0110477 is located on the proximal end on SSC12 (3-4
Mb) and ALGA0039710 is located within the SLA II region on SSC7 (28-29Mb). The
results from this experimental infection indicate that these SNPs partially explain the
variation in viremia, ADG, and immune response. In general, individuals that are
observed homozygotes for the favorable alleles for ALGA0110477 and ALGA0039710
experienced lower viral load and increased ADG than the other genotypes, indicating that
these SNPs are closely linked to a functional loci with a role in immune response and
reducing viral replication.
This study serves as the basis for future research involving the influence of host
genetic variations on the immune response PCV2 and other pathogens. These DNA
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markers can be used for the assembly of a panel of genetic markers used for genetic
selection to efficiently select for individuals that are less susceptible to PCV2.
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TABLES

Table 1. Resource Population
Batch

Number of
Animals

Number of
Litters

Pigs Used Per
Litter

Source

1–4

386

95

4.1

UNL Swine
Research Unit

5-9

588

225

2.6

PigGen Canada
Consortium

Total

974

320

3.04

Table 2. Breeding systems for each resource batch.
Batch

Dam

Sire

Number of
Litters

Pigs
Used/Litter

Animals
Infected

1

Large White x
Landrace

Landrace

19

4.3

81

2

Large White x
Landrace

Nebraska Index
Line

30

3.2

95

3

Large White x
Landrace

Duroc

20

6.0

120

4

Nebraska Index Line

Landrace

26

3.5

90

5

Large White

Landrace

66

1.8

116

6

Large White

Landrace

30

3.0

89

7

Large White

Landrace

37

3.5

131

8

Large White

Landrace

57

2.5

141

9

Large White

Landrace

35

3.2

111

320

3.0

974

Total

109

110

Table 3. Variation Observed Across All Traits
Trait
IgG d 0
IgG d 7
IgG d 14
IgG d 21
IgG d 28
IgM d 0
IgM d 7
IgM d 14
IgM d 21
IgM d 28
ADG 0-7
ADG 7-14
ADG 14-21
ADG 21-28
ADG 0-28
Viremia d 0
Viremia d 7
Viremia d 14
Viremia d 21
Viremia d 28
Viral Load

Mean ± Standard Error
0.78 ± 0.006
0.73 ± 0.005
0.83 ± 0.008
1.69 ± 0.028
2.23 ± 0.032
0.62 ± 0.005
0.68 ± 0.006
1.34 ± 0.020
1.64 ± 0.022
1.32 ± 0.020
0.36 ± 0.007
0.45 ± 0.007
0.48 ± 0.008
0.58 ± 0.009
0.47 ± 0.006
0.03 ± 0.006
1.45 ± 0.039
3.64 ± 0.040
3.42 ± 0.041
2.63 ± 0.041
68.80 ± 0.810

Standard Deviation
0.19
0.15
0.24
0.86
0.95
0.15
0.18
0.61
0.68
0.59
0.22
0.22
0.25
0.28
0.19
0.18
1.20
1.24
1.26
1.25
24.69
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Table 4. Pair-wise Correlations of Residuals Between Viremia and Average Daily Gain.

Viremia d 7
Viremia d 14
Viremia d 21
Viremia d 28

Viral Load

ADG d 0-7
0.051
-0.016
-0.036
-0.016

ADG d 0-7
0.007

ADG d 7-14
-0.081
-0.109 **
-0.177 **
-0.104 *

ADG d 7-14
-0.139 **

ADG d 14-21
-0.115 **
-0.316 **
-0.389 **
-0.308 **

ADG d 14-21
-0.337 **

* P= 0.01
** P= 0.001

ADG d 21-28
-0.068
-0.322 **
-0.384 **
-0.376 **

ADG d 21-28
-0.387 **

ADG d 0-28
-0.074
-0.290 **
-0.371 **
-0.334 **

ADG d 0-28
-0.356 **
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Table 5. Pair-wise Correlations of Residuals Between IgG/IgM and Average Daily Gain.
ADG d 0-7
IgG d 7
IgG d 14
IgG d 21
IgG d 28

-0.009
0.010
0.034
0.013

ADG d 0-7
IgM d 7
IgM d 14
IgM d 21
IgM d 28

-0.014
0.074
0.024
0.040

ADG d 7-14
-0.006
0.052
0.076 *
0.018

ADG d 7-14
0.004
0.038
0.046
-0.045

ADG d 1421
0.007
0.114 **
0.025
0.026

ADG d 2128
0.048
0.092 **
-0.023
-0.020

ADG d 0-28

ADG d 1421
0.045
-0.041
-0.010
-0.109 *

ADG d 2128
0.046
-0.090 *
-0.047
0.144 **

ADG d 0-28

* P= 0.01
** P= 0.001

0.024
0.108 **
0.018
0.009

0.046
-0.044
-0.021
-0.118 **
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Table 6. Pair-wise Correlations of Residuals Between Antibody titres and Viremia.

IgG d 7
IgG d 14
IgG d 21
IgG d 28

Viremia d 7
-0.043
0.118 **
0.206 **
0.165 **

Viremia d 14
-0.059
-0.123 **
0.252 **
0.312 **

Viremia d 21
-0.037
-0.142 **
0.092 *
0.181 **

Viremia d 28
-0.058
-0.109 **
0.075
0.061

Viral Load
-0.066
-0.080
0.260 **
0.270 **

IgM d 7
IgM d 14
IgM d 21
IgM d 28

Viremia d 7
0.112 **
0.281 **
0.114 **
0.082

Viremia d 14
0.020
0.245 **
0.329 **
0.330 **

Viremia d 21
0.027
0.127 **
0.191 **
0.274 **

Viremia d 28
0.012
0.153 **
0.175 **
0.159 **

Viral Load
0.066
0.312 **
0.317 **
0.316 **

* P= 0.01
** P= 0.001
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Table 7. Proportion of Phenotypic Variance Explained By 56,433 SNPs
7
0.19
0.14
0.03

Viremia
IgM
IgG

Trait/ dpi
ADG

0-7
0.13

14
0.52
0.60
0.08

21
0.45
0.44
0.44

Trait/ dpi
Viral Load

0-28
0.64

7-14
0.11

14-21
0.07

28
0.39
0.52
0.38

21-28
0.07

0-28
0.16
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Table 8. Relationships between Genomic prediction values for indicators of PCVAD
Susceptibility

Viremia d 7
Viremia d 14
Viremia d 21
Viremia d 28
Viral Load

ADG d 0-7
0.175 **
-0.017
-0.086 *
-0.052
-0.049

ADG d 7-14
-0.015
-0.070
-0.176 **
-0.109 **
-0.157 **

ADG d 14-21
0.045
-0.082
-0.328 **
-0.269 **
-0.178 **

* P= 0.01
** P= 0.001

ADG d 21-28
0.104 *
0.038
-0.274 **
-0.169 **
-0.210 **

ADG d 0-28
0.081
-0.050
-0.300 **
-0.218 **
-0.247 **
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Table 9. SLA II Haplotypes in Animals Selected for Low and High Viral Load
Haplotype

Number of Animals

Haplotype Frequency

Low

High

Low

High

Whole Data Set

101

1

2

0.04

0.08

0.06

201

1

4

0.04

0.16

0.09

303

4

2

0.14

0.08

0.11

402

1

0

0.04

0.00

0.02

501

6

0

0.21

0.00

0.11

601

5

3

0.18

0.12

0.15

701

10

5

0.36

0.20

0.28

801

0

2

0.00

0.08

0.04

901

0

5

0.00

0.20

0.09

40101

0

2

0.00

0.08

0.04
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FIGURES

Figure 1. Average daily gain (ADG) following experimental infection with PCV2b.
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Figure 2. Variation in viremia following PCV2b experimental infection.
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Figure 3. Association Between Overall Average Daily Gain (0-28 dpi) and Viral Load
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Figure 4. Variation in Immune Response Following PCV2b Experimental Infection IgM
titres shown in blue; IgG titres shown in red.
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Figure 5. Individual immune based on IgM after PCV2b experimental infection.
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Figure 6. Individual immune based on IgG after PCV2b experimental infection.
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Figure 7. Genome-wide Association Analysis Between and Viral Load Following
PCV2b Experimental Infection.

Manhattan plot for viral load. The X-axis represents the Sus scrofa genome, where each
color represents a different chromosome starting with chromosome 1 (SSC1) and ending
with unmarked SNPs. The Y-axis represents the proportion of genetic variance explained
each individual SNP.
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Figure 8. The Number of Favorable Alleles for Viremia
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Figure 9. The Number of Favorable Alleles for IgM
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Figure 10. The Number of Favorable Alleles for IgG
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Figure 11. The Number of Favorable Alleles for ADG
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APPENDIX

Bayesian Analysis WinQTL Output Files:
The following data represents output files from GenSel software used for genome-wide
association study using a Bayesian B approach. These output files represent
approximately 1 Mb windows, which are ranked based off of their genetic variance;
therefore the top windows have the most genetic variation.

Columns of Importance for Window Output File:
Window- the Sus scrofa genome is broken up into 1 Mb windows along the genome
#SNPs- the number of SNPs present in the window
%Var- the percentage of the phenotypic variation represented by the particular window
map_pos0- the chromosome and Mb that the window starts on
map_posn- the chromosome and Mb that the window ends on

Top Windows For Viremia 14 dpi

Top Windows For Viremia 21 dpi
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Top Windows For Viral Load

Top Windows For IgM 14 dpi

Top Windows For IgM 21 dpi
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Top Windows For IgM 28 dpi

Top Windows For IgG d 21

Top Windows For IgG d 28
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Top Windows For ADG 0-28 dpi

